Eli Lilly and Company
Industry and Market Reports

 

List of associated reports

Below is a list of reports where Eli Lilly and Company is mentioned. The list of reports for the company is categorised by Industry, Region and report type. This categorisation along with the number of reports in each category is shown in the region on the left.

Many of the reports mention companies other than Eli Lilly and Company in the same report. This provides an indication of potential competitors or associated to Eli Lilly and Company. The relevance ranking is a measure of how many times both companies are mentioned in the same reported. These associated companies can me clicked to find out more about the company.

View Report: Research and Experts Market Report: Schizophrenia - Current and Future Players

Schizophrenia - Current and Future Players


2016-11-01
GlobalData has released its pharma report, “Schizophrenia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Schizophrenia Market. The report identifies...
  • Market Report
  • Central Nervous System
  • Global
  • $2,995.00
  • Report 05IC-GDHC1067FPR has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC1067FPR
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer (NSCLC) - Current and Future Players

    Non-Small Cell Lung Cancer (NSCLC) - Current and Future Players


    2016-11-03
    GlobalData has released its pharma report, “Non-Small Cell Lung Cancer (NSCLC) - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing NSCLC Market....
  • Market Report
  • Oncology
  • Global
  • $2,995.00
  • Report 05IC-GDHC1066FPR has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC1066FPR
  • View Report: Research and Experts Market Report: Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated...

    Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct’s, ‘Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H2 2016’, provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0703TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0703TDB
  • View Report: Research and Experts Market Report: Metastatic Uveal Melanoma - Pipeline Review, H2 2016

    Metastatic Uveal Melanoma - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Uveal Melanoma – Pipeline Review, H2 2016, provides an overview of the Metastatic Uveal Melanoma (Oncology) pipeline landscape.

    Metastatic uveal...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8909IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8909IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

    Glioblastoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8858IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8858IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H2 2016

    Liver Cancer - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides an overview of the Liver Cancer (Oncology) pipeline landscape.

    Liver cancer starts in the liver. The risk...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8854IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8854IDB
  • View Report: Research and Experts Market Report: Colon Cancer - Pipeline Review, H2 2016

    Colon Cancer - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer – Pipeline Review, H2 2016, provides an overview of the Colon Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts in the large...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8848IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8848IDB
  • View Report: Research and Experts Market Report: Gastroparesis Global Clinical Trials Review, H2, 2016

    Gastroparesis Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Gastroparesis Global Clinical Trials Review, H2, 2016" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3949CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3949CTIDB
  • View Report: Research and Experts Market Report: Serine/Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or...

    Serine/Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct’s, ‘Serine/Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) - Pipeline Review, H2 2016’, provides in depth analysis on Serine/Threonine...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0694TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0694TDB
  • View Report: Research and Experts Market Report: Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase...

    Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 or MAPK3 or EC 2.7.11.24) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct’s, ‘Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 or MAPK3 or EC 2.7.11.24)...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0690TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0690TDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H2 2016

    Colorectal Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8870IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8870IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Myelocytic Leukemia (Oncology) pipeline landscape.

    Acute myelocytic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8869IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8869IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H2 2016

    Melanoma - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma – Pipeline Review, H2 2016, provides an overview of the Melanoma (Oncology) pipeline landscape.

    Melanoma is a tumor that develops as a result of the...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8868IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8868IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H2 2016

    Ovarian Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian cancer is any cancerous growth...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8866IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8866IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H2 2016

    Rheumatoid Arthritis - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis – Pipeline Review, H2 2016, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.

    Rheumatoid arthritis (RA)...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8865IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8865IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H2 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.

    Non-small cell...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8864IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8864IDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Parkinson's Disease – Pipeline Review, H2 2016, provides an overview of the Parkinson's Disease (Central Nervous System) pipeline landscape.

    Parkinson'...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8863IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8863IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H2 2016

    Pancreatic Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

    Pancreatic cancer is a disease in...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8862IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8862IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H2 2016

    Neuropathic Pain - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain – Pipeline Review, H2 2016, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.

    Neuropathic pain, or...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8861IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8861IDB
  • View Report: Research and Experts Market Report: Cyclin Dependent Kinase 6 (Cell Division Protein Kinase 6 or Serine/Threonine Protein Kinase PLSTIRE or CDK6 or EC 2.7.11.22) - Pipeline...

    Cyclin Dependent Kinase 6 (Cell Division Protein Kinase 6 or Serine/Threonine Protein Kinase PLSTIRE or CDK6 or EC 2.7.11.22) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct’s, ‘Cyclin Dependent Kinase 6 (Cell Division Protein Kinase 6 or Serine/Threonine Protein Kinase PLSTIRE or CDK6 or EC 2.7.11.22) - Pipeline Review, H2 2016’, provides in depth analysis on Cyclin Dependent Kinase 6...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0685TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0685TDB
  • View Report: Research and Experts Market Report: Tumor Necrosis Factor Receptor Superfamily Member 1A (Tumor Necrosis Factor Receptor 1 or Tumor Necrosis Factor Receptor Type I or...

    Tumor Necrosis Factor Receptor Superfamily Member 1A (Tumor Necrosis Factor Receptor 1 or Tumor Necrosis Factor Receptor Type I or p55 or p60 or CD120a or TNFRSF1A) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct’s, ‘Tumor Necrosis Factor Receptor Superfamily Member 1A (Tumor Necrosis Factor Receptor 1 or Tumor Necrosis Factor Receptor Type I or p55 or p60 or CD120a or TNFRSF1A) - Pipeline Review, H2 2016’, provides in depth...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0682TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0682TDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H2 2016

    Prostate Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.

    Prostate cancer is a form of cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8860IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8860IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H2 2016

    Multiple Sclerosis - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis – Pipeline Review, H2 2016, provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape.

    Multiple sclerosis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8845IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8845IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) – Pipeline Review, H2 2016, provides an overview of the Multiple Myeloma (Kahler Disease) (Oncology) pipeline landscape.

    Multiple...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8844IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8844IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H2 2016

    Hypertension - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension – Pipeline Review, H2 2016, provides an overview of the Hypertension (Cardiovascular) pipeline landscape.

    Hypertension, also referred to as high...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8829IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8829IDB
  • View Report: Research and Experts Market Report: Sicca Syndrome (Sjogren) - Pipeline Review, H2 2016

    Sicca Syndrome (Sjogren) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sicca Syndrome (Sjogren) – Pipeline Review, H2 2016, provides an overview of the Sicca Syndrome (Sjogren) (Immunology) pipeline landscape.

    Sjogren's syndrome...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8821IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8821IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

    Kidney...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8816IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8816IDB
  • View Report: Research and Experts Market Report: Alcohol Addiction Global Clinical Trials Review, H2, 2016

    Alcohol Addiction Global Clinical Trials Review, H2, 2016


    2016-11-22
    GlobalData's clinical trial report, “Alcohol Addiction Global Clinical Trials Review, H2, 2016" provides an overview of Alcohol Addiction clinical trials scenario. This report provides top line data relating to the clinical trials on Alcohol...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3915CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3915CTIDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016

    Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) clinical trials scenario. This report provides top line data...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3879CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3879CTIDB
  • View Report: Research and Experts Market Report: Thymic Carcinoma Global Clinical Trials Review, H2, 2016

    Thymic Carcinoma Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Thymic Carcinoma Global Clinical Trials Review, H2, 2016" provides an overview of Thymic Carcinoma clinical trials scenario. This report provides top line data relating to the clinical trials on Thymic...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3876CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3876CTIDB
  • View Report: Research and Experts Market Report: Synovial Sarcoma Global Clinical Trials Review, H2, 2016

    Synovial Sarcoma Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Synovial Sarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Synovial Sarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Synovial...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3875CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3875CTIDB
  • View Report: Research and Experts Market Report: Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016

    Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016" provides an overview of Recurrent Malignant Glioma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3874CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3874CTIDB
  • View Report: Research and Experts Market Report: Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

    Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) targeted pipeline...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0672TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0672TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0670TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0670TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0669TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0669TDB
  • View Report: Research and Experts Market Report: MAP Kinase Interacting Serine/Threonine Protein Kinase 1 (MAP Kinase Signal Integrating Kinase 1 or MKNK1 or EC 2.7.11.1) - Pipeline...

    MAP Kinase Interacting Serine/Threonine Protein Kinase 1 (MAP Kinase Signal Integrating Kinase 1 or MKNK1 or EC 2.7.11.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘MAP Kinase Interacting Serine/Threonine Protein Kinase 1 (MAP Kinase Signal Integrating Kinase 1 or MKNK1 or EC 2.7.11.1) - Pipeline Review, H2 2016’, provides in depth analysis on MAP Kinase Interacting Serine/Threonine...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0667TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0667TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0657TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0657TDB
  • View Report: Research and Experts Market Report: Liposarcoma - Pipeline Review, H2 2016

    Liposarcoma - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liposarcoma – Pipeline Review, H2 2016, provides an overview of the Liposarcoma (Oncology) pipeline landscape.

    Liposarcoma is a malignant tumor of fatty tissue....

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8815IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8815IDB
  • View Report: Research and Experts Market Report: Hyperglycemia - Pipeline Review, H2 2016

    Hyperglycemia - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperglycemia – Pipeline Review, H2 2016, provides an overview of the Hyperglycemia (Metabolic Disorders) pipeline landscape.

    Hyperglycemia is a condition that...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8814IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8814IDB
  • View Report: Research and Experts Market Report: Neuroendocrine Tumors - Pipeline Review, H2 2016

    Neuroendocrine Tumors - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors – Pipeline Review, H2 2016, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.

    Neuroendocrine tumor begins...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8809IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8809IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H2 2016, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline landscape.

    Bi...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8808IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8808IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H2 2016

    Metastatic Breast Cancer - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Breast Cancer (Oncology) pipeline landscape.

    Metastatic breast cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8794IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8794IDB
  • View Report: Research and Experts Market Report: Axial Spondyloarthritis - Pipeline Review, H2 2016

    Axial Spondyloarthritis - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Axial Spondyloarthritis - Pipeline Review, H2 2016, provides an overview of the Axial Spondyloarthritis (Musculoskeletal Disorders) pipeline landscape.

    Axial spondyl...

  • Market Report
  • Musculoskeletal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8764IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8764IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma (also known...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8759IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8759IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H2 2016

    Hepatocellular Carcinoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatocellular Carcinoma - Pipeline Review, H2 2016, provides an overview of the Hepatocellular Carcinoma (Oncology) pipeline landscape.

    Hepatocellular carcinoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8748IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8748IDB
  • View Report: Research and Experts Market Report: Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016

    Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Extrahepatic Bile Duct Cancer clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3873CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3873CTIDB
  • View Report: Research and Experts Market Report: Liposarcoma Global Clinical Trials Review, H2, 2016

    Liposarcoma Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Liposarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Liposarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Liposarcoma. Report...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3871CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3871CTIDB
  • View Report: Research and Experts Market Report: Intestinal Cancer Global Clinical Trials Review, H2, 2016

    Intestinal Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Intestinal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Intestinal...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3866CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3866CTIDB
  • View Report: Research and Experts Company Report: Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review

    Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review


    2016-11-29
    Phibro Animal Health Corp (Phibro), a subsidiary of BFI Co., LLC, is a diversified animal health, and mineral nutrition company. It develops, manufactures and markets a broad range of animal health and nutritional products for a broad range of food animal...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH32199FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH32199FSA
  • View Report: Research and Experts Market Report: US Market Report for Insulin Pumps 2017 - MedCore

    US Market Report for Insulin Pumps 2017 - MedCore


    2016-11-01
    The total U.S. market for insulin pumps can be segmented by pump type, yielding three segments: traditional insulin pumps, patch insulin pumps and simple insulin pumps. In 2016, the largest segment in the total insulin pump market was the traditional...
  • Market Report
  • Medical Devices
  • United States
  • $5,495.00
  • Report 01EK-iDATA_USDD17_MC_PUM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_PUM
  • View Report: Research and Experts Market Report: US Market Report for Insulin Syringes 2017 - MedCore

    US Market Report for Insulin Syringes 2017 - MedCore


    2016-11-01
    The U.S. insulin syringe market can be segmented by syringe type, yielding two segments: conventional insulin syringes and safety insulin syringes. In 2016, the largest segment in the total insulin syringe market was the conventional insulin syringe segme...
  • Market Report
  • Medical Devices
  • United States
  • $4,495.00
  • Report 01EK-iDATA_USDD17_MC_IS has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_IS
  • View Report: Research and Experts Market Report: US Market Report for Insulin 2017 - MedCore

    US Market Report for Insulin 2017 - MedCore


    2016-11-01
    The U.S. insulin market can be segmented by insulin type, yielding four segments: long-acting insulin, rapid-acting insulin, premixed insulin and human insulin. In 2016, the largest segment in the total insulin market was long-acting insulin. Patent expir...
  • Market Report
  • Medical Devices
  • United States
  • $5,495.00
  • Report 01EK-iDATA_USDD17_MC_IM has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_IM
  • View Report: Research and Experts Market Report: US Market Report for Continuous Glucose Monitoring 2017 - MedCore

    US Market Report for Continuous Glucose Monitoring 2017 - MedCore


    2016-11-01
    The U.S. continuous glucose monitoring (CGM) market can be segmented by setting, yielding two segments: professional CGM and personal CGM. In 2016, the largest segment in the total CGM market was the personal CGM segment. Growth is expected to continue...
  • Market Report
  • Medical Devices
  • United States
  • $5,495.00
  • Report 01EK-iDATA_USDD17_MC_CGM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_CGM
  • View Report: Research and Experts Market Report: US Market Report for Lancet and Lancing Devices 2017 - MedCore

    US Market Report for Lancet and Lancing Devices 2017 - MedCore


    2016-11-01
    The lancet and lancing device market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total lancet and lancing device market was the personal segment. Personal lancets and lancing devices...
  • Market Report
  • Medical Devices
  • United States
  • $4,495.00
  • Report 01EK-iDATA_USDD17_MC_LL has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_LL
  • View Report: Research and Experts Market Report: US Market Report for Blood Glucose Test Strips 2017 - MedCore

    US Market Report for Blood Glucose Test Strips 2017 - MedCore


    2016-11-01
    The U.S. blood glucose test strip market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose test strip market was the personal segment. Personal test strips are used by...
  • Market Report
  • Medical Devices
  • United States
  • $5,495.00
  • Report 01EK-iDATA_USDD17_MC_BGT has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_BGT
  • View Report: Research and Experts Market Report: US Market Report for Blood Glucose Meters 2017 - MedCore

    US Market Report for Blood Glucose Meters 2017 - MedCore


    2016-11-01
    The U.S. blood glucose meter market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose meter market was the personal segment. Personal blood glucose meters are used by...
  • Market Report
  • Medical Devices
  • United States
  • $4,495.00
  • Report 01EK-iDATA_USDD17_MC_BGM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_BGM
  • View Report: Research and Experts Market Report: US Procedure Numbers for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedPro

    US Procedure Numbers for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedPro


    2016-11-01
    Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost....
  • Market Report
  • Medical Devices
  • United States
  • $1,995.00
  • Report 01EK-iDATA_USDD17_MP has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MP
  • View Report: Research and Experts Market Report: US Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedView

    US Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedView


    2016-11-01
    Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost....
  • Market Report
  • Medical Devices
  • United States
  • $3,995.00
  • Report 01EK-iDATA_USDD17_MV has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MV
  • View Report: Research and Experts Market Report: Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin...

    Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin Like Protease PC9 or PCSK9 or EC 3.4.21.) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin Like Protease PC9 or PCSK9 or EC 3.4.21.) - Pipeline Review, H2 2016’, provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0629TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0629TDB
  • View Report: Research and Experts Market Report: Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Pipeline Review, H2 2016

    Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Pipeline Review, H2 2016’, provides in depth analysis on Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0621TDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC0621TDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape.

    Chronic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8731IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8731IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H2 2016

    Myelodysplastic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides an overview of the Myelodysplastic Syndrome (Oncology) pipeline landscape.

    Myelodysplastic syndrome...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8729IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8729IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H2 2016

    Metastatic Colorectal Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic Colorectal Cancer (Oncology) pipeline landscape.

    Metastatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8728IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8728IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8713IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8713IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2016

    Epithelial Ovarian Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epithelial Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Epithelial Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian epithelial...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8712IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8712IDB
  • View Report: Research and Experts Market Report: Gallbladder Cancer - Pipeline Review, H2 2016

    Gallbladder Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gallbladder Cancer – Pipeline Review, H2 2016, provides an overview of the Gallbladder Cancer (Oncology) pipeline landscape.

    Gallbladder cancer is a cancer...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8710IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8710IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H2 2016

    Small-Cell Lung Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape.

    Small cell lung cancer...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8706IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8706IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Refractory Acute Myeloid Leukemia (Oncology) pipeline landscape.

    The...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8705IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8705IDB
  • View Report: Research and Experts Market Report: Anorexia Nervosa Global Clinical Trials Review, H2, 2016

    Anorexia Nervosa Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Anorexia Nervosa Global Clinical Trials Review, H2, 2016" provides an overview of Anorexia Nervosa clinical trials scenario. This report provides top line data relating to the clinical trials on Anorexia...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3855CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3855CTIDB
  • View Report: Research and Experts Market Report: Hyperalgesia Global Clinical Trials Review, H2, 2016

    Hyperalgesia Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Hyperalgesia Global Clinical Trials Review, H2, 2016" provides an overview of Hyperalgesia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperalgesia....
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3845CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3845CTIDB
  • View Report: Research and Experts Market Report: Nicotine Addiction Global Clinical Trials Review, H2, 2016

    Nicotine Addiction Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Nicotine Addiction Global Clinical Trials Review, H2, 2016" provides an overview of Nicotine Addiction clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3844CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3844CTIDB
  • View Report: Research and Experts Market Report: Optic Neuropathy Global Clinical Trials Review, H2, 2016

    Optic Neuropathy Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Optic Neuropathy Global Clinical Trials Review, H2, 2016" provides an overview of Optic Neuropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Optic...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3833CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3833CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

    PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024


    2016-09-01
    Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels of inattention, impulsivity, and hyperactivity, either alone or in combination that have a significant social impact through disruptions at school, work, home, and in...
  • Market Report
  • Central Nervous System
  • Global
  • $10,995.00
  • Report 05IC-GDHC125PIDR has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC125PIDR
  • View Report: Research and Experts Market Report: C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide...

    C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - Pipeline Review, H2


    2016-10-26
    Global Markets Direct’s, ‘C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0614TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0614TDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H2 2016

    Migraine - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine – Pipeline Review, H2 2016, provides an overview of the Migraine (Central Nervous System) pipeline landscape.

    Migraine is a disorder characterized...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8702IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8702IDB
  • View Report: Research and Experts Market Report: Malignant Pleural Mesothelioma - Pipeline Review, H2 2016

    Malignant Pleural Mesothelioma - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malignant Pleural Mesothelioma – Pipeline Review, H2 2016, provides an overview of the Malignant Pleural Mesothelioma (Oncology) pipeline landscape.

    Malignant...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8690IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8690IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H2 2016

    Endometrial Cancer - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer – Pipeline Review, H2 2016, provides an overview of the Endometrial Cancer (Oncology) pipeline landscape.

    Endometrial cancer is cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8689IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8689IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adenocarcinoma Of The Gastroesophageal Junction – Pipeline Review, H2 2016, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8688IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8688IDB
  • View Report: Research and Experts Market Report: Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2016

    Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2016’, provides in depth analysis on Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0592TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0592TDB
  • View Report: Research and Experts Market Report: Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2016

    Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2016’, provides in depth analysis on Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0586TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0586TDB
  • View Report: Research and Experts Market Report: Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

    Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) – Pipeline Review, H2 2016, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8770IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8770IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H2 2016

    Tuberculosis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis – Pipeline Review, H2 2016, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape.

    Tuberculosis, commonly known as TB,...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8686IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8686IDB
  • View Report: Research and Experts Market Report: Hypoparathyroidism - Pipeline Review, H2 2016

    Hypoparathyroidism - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypoparathyroidism – Pipeline Review, H2 2016, provides an overview of the Hypoparathyroidism (Hormonal Disorders) pipeline landscape.

    Hypoparathyroidism is...

  • Market Report
  • Hormonal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8685IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8685IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H2 2016

    Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Renal Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Renal Cell Carcinoma (Oncology) pipeline landscape.

    Renal cell carcinoma (RCC,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8682IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8682IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H2 2016

    Psoriatic Arthritis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriatic Arthritis – Pipeline Review, H2 2016, provides an overview of the Psoriatic Arthritis (Musculoskeletal Disorders) pipeline landscape.

    Psoriatic arthritis...

  • Market Report
  • Musculoskeletal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8680IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8680IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Lymphocytic Leukemia (Oncology) pipeline landscape.

    Acute lymphocytic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8640IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8640IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2016

    Systemic Lupus Erythematosus - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H2 2016, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.

    Systemic...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8637IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8637IDB
  • View Report: Research and Experts Project Profile: Eli Lilly and Company - Strategy, SWOT and Corporate Finance Report

    Eli Lilly and Company - Strategy, SWOT and Corporate Finance Report


    2017-01-31
    Eli Lilly and Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions,...
  • Project Profile
  • Life Sciences
  • United States
  • $175.00
  • Report 05IK-83105F16-88D8-4BB5-8D6C-59 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-83105F16-88D8-4BB5-8D6C-59
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016

    Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Non-Small Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3815CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3815CTIDB
  • View Report: Research and Experts Market Report: Dyslipidemia Global Clinical Trials Review, H2, 2016

    Dyslipidemia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Dyslipidemia Global Clinical Trials Review, H2, 2016" provides an overview of Dyslipidemia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyslipidemia....
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3809CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3809CTIDB
  • View Report: Research and Experts Market Report: Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2016

    Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3802CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3802CTIDB
  • View Report: Research and Experts Market Report: Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016

    Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016" provides an overview of Post Menopausal Osteoporosis clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3794CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3794CTIDB
  • View Report: Research and Experts Market Report: Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H2 2016

    Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H2 2016’, provides in depth analysis on Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0584TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0584TDB
  • View Report: Research and Experts Market Report: Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Pipeline Review, H2 2016

    Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Pipeline Review, H2 2016’, provides in depth analysis on Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0580TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0580TDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8644IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8644IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2016

    Bladder Cancer - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer – Pipeline Review, H2 2016, provides an overview of the Bladder Cancer (Oncology) pipeline landscape.

    Bladder cancer occurs in tissues of the...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8622IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8622IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H2 2016

    Obesity - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obesity – Pipeline Review, H2 2016, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape.

    Obesity is defined as having an excessive...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8621IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8621IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H2 2016

    Type 2 Diabetes - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes – Pipeline Review, H2 2016, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.

    Type 2 diabetes is a chronic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8585IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8585IDB
  • View Report: Research and Experts Market Report: Axial Spondyloarthritis Global Clinical Trials Review, H2, 2016

    Axial Spondyloarthritis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Axial Spondyloarthritis Global Clinical Trials Review, H2, 2016" provides an overview of Axial Spondyloarthritis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3789CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3789CTIDB
  • View Report: Research and Experts Market Report: Degenerative Scoliosis Global Clinical Trials Review, H2, 2016

    Degenerative Scoliosis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Degenerative Scoliosis Global Clinical Trials Review, H2, 2016" provides an overview of Degenerative Scoliosis clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3788CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3788CTIDB
  • View Report: Research and Experts Market Report: Fibromyalgia Global Clinical Trials Review, H2, 2016

    Fibromyalgia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Fibromyalgia Global Clinical Trials Review, H2, 2016" provides an overview of Fibromyalgia clinical trials scenario. This report provides top line data relating to the clinical trials on Fibromyalgia....
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3781CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3781CTIDB
  • View Report: Research and Experts Market Report: Schizophrenia Global Clinical Trials Review, H2, 2016

    Schizophrenia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Schizophrenia Global Clinical Trials Review, H2, 2016" provides an overview of Schizophrenia clinical trials scenario. This report provides top line data relating to the clinical trials on Schizophrenia....
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3779CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3779CTIDB
  • View Report: Research and Experts Market Report: Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2016

    Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2016" provides an overview of Post-Traumatic Stress Disorder (PTSD) clinical trials scenario. This report provides top line data...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3777CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3777CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

    PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025


    2016-08-08
    Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality in the world. The term acute coronary syndrome (ACS) applies to a spectrum of acute CVD states that are precipitated by coronary artery occlusi...
  • Market Report
  • Automotive
  • Global
  • $10,995.00
  • Report 05IC-GDHC131PIDR has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC131PIDR
  • View Report: Research and Experts Market Report: Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA...

    Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct’s, ‘Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) - Pipeline Review, H2 2016’, provides in depth analysis on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0562TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0562TDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2016, provides an overview of the B-Cell Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8609IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8609IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Relapsed Acute Myeloid Leukemia (Oncology) pipeline landscape.

    Return...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8605IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8605IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H2 2016

    Osteoarthritis Pain - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis Pain – Pipeline Review, H2 2016, provides an overview of the Osteoarthritis Pain (Central Nervous System) pipeline landscape.

    Osteoarthritis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8600IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8600IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H2 2016

    Ulcerative Colitis - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis – Pipeline Review, H2 2016, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.

    Ulcerative Colitis (Colitis...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8598IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8598IDB
  • View Report: Research and Experts Market Report: Osteoporosis - Pipeline Review, H2 2016

    Osteoporosis - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis – Pipeline Review, H2 2016, provides an overview of the Osteoporosis (Metabolic Disorders) pipeline landscape.

    Osteoporosis, or thinning bones,...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8638IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8638IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H2 2016

    Fallopian Tube Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fallopian Tube Cancer – Pipeline Review, H2 2016, provides an overview of the Fallopian Tube Cancer (Oncology) pipeline landscape.

    Fallopian tube cancer is...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8595IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8595IDB
  • View Report: Research and Experts Market Report: Treatment Resistant Depression - Pipeline Review, H2 2016

    Treatment Resistant Depression - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Treatment Resistant Depression – Pipeline Review, H2 2016, provides an overview of the Treatment Resistant Depression (Central Nervous System) pipeline landscape.

    Tr...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8591IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8591IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H2 2016

    Head And Neck Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

    Head and Neck Cancer is a cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8588IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8588IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2016

    Gastric Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Pipeline Review, H2 2016, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

    Gastric cancer, also called stomach cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8584IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8584IDB
  • View Report: Research and Experts Market Report: Post Menopausal Osteoporosis - Pipeline Review, H2 2016

    Post Menopausal Osteoporosis - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis – Pipeline Review, H2 2016, provides an overview of the Post Menopausal Osteoporosis (Metabolic Disorders) pipeline landscape.

    Postmenop...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8575IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8575IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Recurrent Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape....
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8562IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8562IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plaque Psoriasis (Psoriasis Vulgaris) – Pipeline Review, H2 2016, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) pipeline landscape.

    ...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8559IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8559IDB
  • View Report: Research and Experts Market Report: Pancreatic Ductal Adenocarcinoma - Pipeline Review, H2 2016

    Pancreatic Ductal Adenocarcinoma - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Ductal Adenocarcinoma – Pipeline Review, H2 2016, provides an overview of the Pancreatic Ductal Adenocarcinoma (Oncology) pipeline landscape.

    Pancreatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8532IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8532IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hormone Refractory Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Hormone Refractory Prostate Cancer (Oncology) pipeline landscape.

    Prostate...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8504IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8504IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H2 2016

    Mild Cognitive Impairment - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mild Cognitive Impairment – Pipeline Review, H2 2016, provides an overview of the Mild Cognitive Impairment (Central Nervous System) pipeline landscape.

    Mild...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8518IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8518IDB
  • View Report: Research and Experts Market Report: Malignant Pleural Effusion Global Clinical Trials Review, H2, 2016

    Malignant Pleural Effusion Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Malignant Pleural Effusion Global Clinical Trials Review, H2, 2016" provides an overview of Malignant Pleural Effusion clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3771CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3771CTIDB
  • View Report: Research and Experts Market Report: Pleural Effusion Global Clinical Trials Review, H2, 2016

    Pleural Effusion Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Pleural Effusion Global Clinical Trials Review, H2, 2016" provides an overview of Pleural Effusion clinical trials scenario. This report provides top line data relating to the clinical trials on Pleural...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3770CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3770CTIDB
  • View Report: Research and Experts Market Report: Osteomyelitis Global Clinical Trials Review, H2, 2016

    Osteomyelitis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Osteomyelitis Global Clinical Trials Review, H2, 2016" provides an overview of Osteomyelitis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteomyelitis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3767CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3767CTIDB
  • View Report: Research and Experts Market Report: Ischemic Stroke Global Clinical Trials Review, H2, 2016

    Ischemic Stroke Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Ischemic Stroke Global Clinical Trials Review, H2, 2016" provides an overview of Ischemic Stroke clinical trials scenario. This report provides top line data relating to the clinical trials on Ischemic...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3757CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3757CTIDB
  • View Report: Research and Experts Market Report: Pulmonary Hypertension Global Clinical Trials Review, H2, 2016

    Pulmonary Hypertension Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Pulmonary Hypertension Global Clinical Trials Review, H2, 2016" provides an overview of Pulmonary Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3753CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3753CTIDB
  • View Report: Research and Experts Market Report: Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016

    Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Acute Coronary Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3750CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3750CTIDB
  • View Report: Research and Experts Market Report: Urinary Incontinence Global Clinical Trials Review, H2, 2016

    Urinary Incontinence Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Urinary Incontinence Global Clinical Trials Review, H2, 2016" provides an overview of Urinary Incontinence clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3748CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3748CTIDB
  • View Report: Research and Experts Market Report: Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2016

    Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2016" provides an overview of Benign Prostatic Hyperplasia clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3740CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3740CTIDB
  • View Report: Research and Experts Market Report: Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor...

    Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0548TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0548TDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H2 2016

    Psoriasis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8494IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8494IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H2 2016

    Metastatic Melanoma - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Metastatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8473IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8473IDB
  • View Report: Research and Experts Market Report: Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016

    Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of Natural Killer Cell Lymphomas clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3727CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3727CTIDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016

    Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016" provides an overview of Transitional Cell Cancer (Urothelial Cell Cancer) clinical trials scenario. This report...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3724CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3724CTIDB
  • View Report: Research and Experts Market Report: Mast Cell Leukemia Global Clinical Trials Review, H2, 2016

    Mast Cell Leukemia Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Mast Cell Leukemia Global Clinical Trials Review, H2, 2016" provides an overview of Mast Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3723CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3723CTIDB
  • View Report: Research and Experts Market Report: Malignant Pleural Mesothelioma Global Clinical Trials Review, H2, 2016

    Malignant Pleural Mesothelioma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Malignant Pleural Mesothelioma Global Clinical Trials Review, H2, 2016" provides an overview of Malignant Pleural Mesothelioma clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3721CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3721CTIDB
  • View Report: Research and Experts Market Report: HER2-Negative Breast Cancer - Current and Future Players

    HER2-Negative Breast Cancer - Current and Future Players


    2015-01-31
    GlobalData has released its pharma report, “HER2-Negative Breast Cancer - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Insomnia Market. The...
  • Market Report
  • Oncology
  • Global
  • $2,995.00
  • Report 05IC-GDHC1063FPR has a star rating of 3.7 out of 5
  • Go to More information on Report 05IC-GDHC1063FPR
  • View Report: Research and Experts Market Report: Type 1 Diabetes - Current and Future Players

    Type 1 Diabetes - Current and Future Players


    2015-03-01
    GlobalData has released its pharma report, “Type 1 Diabetes - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Insomnia Market. The report identifies...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,995.00
  • Report 05IC-GDHC1061FPR has a star rating of 3.7 out of 5
  • Go to More information on Report 05IC-GDHC1061FPR
  • View Report: Research and Experts Market Report: Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Pipeline Review, H2 2016

    Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Pipeline Review, H2 2016’, provides in depth analysis on Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0520TDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC0520TDB
  • View Report: Research and Experts Market Report: Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H2 2016

    Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H2 2016’, provides in depth analysis on Gastric Inhibitory Polypeptide Receptor (Glucose...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0518TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0518TDB
  • View Report: Research and Experts Market Report: Mitogen Activated Protein Kinase 14 (Cytokine Suppressive Anti Inflammatory Drug Binding Protein or Mitogen Activated Protein Kinase...

    Mitogen Activated Protein Kinase 14 (Cytokine Suppressive Anti Inflammatory Drug Binding Protein or Mitogen Activated Protein Kinase p38 Alpha or MAP Kinase MXI2 or MAX Interacting Protein 2 or Stress Activated Protein Kinase 2a or MAPK14 or EC 2.7.11.24)


    2016-09-14
    Global Markets Direct’s, ‘Mitogen Activated Protein Kinase 14 (Cytokine Suppressive Anti Inflammatory Drug Binding Protein or Mitogen Activated Protein Kinase p38 Alpha or MAP Kinase MXI2 or MAX Interacting Protein 2 or Stress Activated Protein...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0514TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0514TDB
  • View Report: Research and Experts Market Report: Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016

    Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0511TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0511TDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H2 2016

    Chronic Pain - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H2 2016’, provides an overview of the Chronic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Chronic Pain, complete...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8545IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8545IDB
  • View Report: Research and Experts Market Report: Pulmonary Arterial Hypertension - Pipeline Review, H2 2016

    Pulmonary Arterial Hypertension - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Pulmonary Arterial Hypertension - Pipeline Review, H2 2016’, provides an overview of the Pulmonary Arterial Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8450IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8450IDB
  • View Report: Research and Experts Market Report: Anxiety Disorders - Pipeline Review, H2 2016

    Anxiety Disorders - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H2 2016’, provides an overview of the Anxiety Disorders pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anxiety...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8433IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8433IDB
  • View Report: Research and Experts Market Report: Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016

    Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016’, provides an overview of the Congestive Heart Failure (Heart Failure) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8423IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8423IDB
  • View Report: Research and Experts Market Report: Sepsis Global Clinical Trials Review, H2, 2016

    Sepsis Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Sepsis Global Clinical Trials Review, H2, 2016" provides an overview of Sepsis clinical trials scenario. This report provides top line data relating to the clinical trials on Sepsis. Report includes...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3686CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3686CTIDB
  • View Report: Research and Experts Market Report: Fibromyalgia - Current and Future Players

    Fibromyalgia - Current and Future Players


    2015-05-01
    GlobalData has released its pharma report, “Fibromyalgia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Fibromyalgia Market. The report identifies...
  • Market Report
  • Central Nervous System
  • Global
  • $2,995.00
  • Report 05IC-GDHC1058FPR has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC1058FPR
  • View Report: Research and Experts Market Report: Dyslipidemia - Current and Future Players

    Dyslipidemia - Current and Future Players


    2015-05-05
    GlobalData has released its pharma report, “Dyslipidemia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Dyslipidemia Market. The report identifies...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,995.00
  • Report 05IC-GDHC1056FPR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC1056FPR
  • View Report: Research and Experts Market Report: DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016

    DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016’, provides in depth analysis on DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0501TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0501TDB
  • View Report: Research and Experts Market Report: TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine...

    TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Protein Kinase Receptor R4 or Transforming Growth Factor Beta Receptor Type I or ALK5 or TGFBR1 or EC 2.7.11.30) - Pipel


    2016-08-31
    Global Markets Direct’s, ‘TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Protein Kinase Receptor R4 or Transforming Growth Factor Beta Receptor Type I or...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0492TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0492TDB
  • View Report: Research and Experts Market Report: Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2016

    Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2016’, provides an overview of the Metastatic Hepatocellular Carcinoma (HCC) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8419IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8419IDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H2 2016

    Dyslipidemia - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H2 2016’, provides an overview of the Dyslipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dyslipidemia, complete...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8412IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8412IDB
  • View Report: Research and Experts Market Report: European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

    European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView


    2016-09-01
    The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence of diabetes in Europe and technological advancements...
  • Market Report
  • Medical Devices
  • Europe
  • $4,995.00
  • Report 01EK-iDATA_EUDD16_MV has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MV
  • View Report: Research and Experts Market Report: European Market Report for Insulin Syringes 2016 - MedCore

    European Market Report for Insulin Syringes 2016 - MedCore


    2016-09-01
    The insulin syringe market is a fast declining segment. Although the product was once a popular method of injecting insulin, patients have transitioned towards new technologies such as insulin pens and pumps, thereby cannibalizing the insulin syringe...
  • Market Report
  • Medical Devices
  • Europe
  • $4,995.00
  • Report 01EK-iDATA_EUDD16_MC_IS has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_IS
  • View Report: Research and Experts Market Report: European Market Report for Insulin Pumps 2016 - MedCore

    European Market Report for Insulin Pumps 2016 - MedCore


    2016-09-01
    The total European market for insulin pumps comprises the traditional insulin pump segment and the insulin patch pump market. In 2015, the largest segment in the total insulin pump market was the traditional pump segment, representing over 80% of the...
  • Market Report
  • Medical Devices
  • Europe
  • $6,495.00
  • Report 01EK-iDATA_EUDD16_MC_PUM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_PUM
  • View Report: Research and Experts Market Report: European Market Report for Insulin Pens 2016 - MedCore

    European Market Report for Insulin Pens 2016 - MedCore


    2016-09-01
    The total European market for insulin pens comprises the prefilled pen segment, the pen cartridge segment, the pen needle segment and the safety pen needle segment. In 2015, the largest segment in the total insulin pen market was the prefilled pen segment...
  • Market Report
  • Medical Devices
  • Europe
  • $6,495.00
  • Report 01EK-iDATA_EUDD16_MC_PEN has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_PEN
  • View Report: Research and Experts Market Report: European Market Report for Modern Insulin 2016 - MedCore

    European Market Report for Modern Insulin 2016 - MedCore


    2016-09-01
    The European modern insulin market can be segmented by insulin type, yielding three segments: long-acting insulin, rapid-acting insulin and premixed insulin. In 2015, the largest segment in the total modern insulin market was the long-acting insulin segme...
  • Market Report
  • Medical Devices
  • Europe
  • $5,995.00
  • Report 01EK-iDATA_EUDD16_MC_IM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_IM
  • View Report: Research and Experts Market Report: European Market Report for Flash Glucose Monitoring 2016 - MedCore

    European Market Report for Flash Glucose Monitoring 2016 - MedCore


    2016-09-01
    The European FGM market comprises the FGM reader segment and the FGM sensor segment. The business model for FGM is similar to traditional blood glucose meters and CGM, where the reader is the base equipment and the majority of sales are made from the...
  • Market Report
  • Medical Devices
  • Europe
  • $5,495.00
  • Report 01EK-iDATA_EUDD16_MC_FGM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_FGM
  • View Report: Research and Experts Market Report: European Market Report for Continuous Glucose Monitoring 2016 - MedCore

    European Market Report for Continuous Glucose Monitoring 2016 - MedCore


    2016-09-01
    The European CGM market comprises the CGM system segment and the CGM sensor segment. The business model for CGM is similar to traditional blood glucose meters, where the CGM system is the base equipment and the majority of sales are made from the disposab...
  • Market Report
  • Medical Devices
  • Europe
  • $5,495.00
  • Report 01EK-iDATA_EUDD16_MC_CGM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_CGM
  • View Report: Research and Experts Market Report: European Market Report for Lancet and Lancing Devices 2016 - MedCore

    European Market Report for Lancet and Lancing Devices 2016 - MedCore


    2016-09-01
    The value of the lancet and lancing device increased in 2015 and modest growth is expected to continue over the forecast period, driven by increasing unit sales and limited by ASP erosion. Unit sales growth will be driven by the increasing patient populat...
  • Market Report
  • Medical Devices
  • Europe
  • $4,995.00
  • Report 01EK-iDATA_EUDD16_MC_LL has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_LL
  • View Report: Research and Experts Market Report: European Market Report for Blood Glucose Test Strips 2016 - MedCore

    European Market Report for Blood Glucose Test Strips 2016 - MedCore


    2016-09-01
    The value of the blood glucose test strip market increased in 2015 and modest growth is expected to continue over the forecast period, driven by increasing unit sales and limited by ASP erosion. Unit sales growth will be driven by the increasing patient...
  • Market Report
  • Medical Devices
  • Europe
  • $4,995.00
  • Report 01EK-iDATA_EUDD16_MC_BGT has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_BGT
  • View Report: Research and Experts Market Report: European Market Report for Blood Glucose Meters 2016 - MedCore

    European Market Report for Blood Glucose Meters 2016 - MedCore


    2016-09-01
    The value of the blood glucose meter market increased in 2015 and modest growth is expected to continue over the forecast period, driven by increasing unit sales and limited by ASP erosion. Unit sales growth will be driven by the increasing patient popula...
  • Market Report
  • Medical Devices
  • Europe
  • $4,995.00
  • Report 01EK-iDATA_EUDD16_MC_BGM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_BGM
  • View Report: Research and Experts Market Report: European Market Report for Traditional Blood Glucose Monitoring 2016 - MedCore

    European Market Report for Traditional Blood Glucose Monitoring 2016 - MedCore


    2016-09-01
    The European traditional blood glucose monitoring market is comprised of the blood glucose meter segment, the blood glucose test strip segment, and the lancet and lancing device segment. In 2015, the largest segment in the traditional blood glucose monito...
  • Market Report
  • Medical Devices
  • Europe
  • $4,995.00
  • Report 01EK-iDATA_EUDD16_MC_TBG has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_TBG
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016

    Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016


    2016-08-24
    GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016" provides an overview of Glioblastoma Multiforme (GBM) clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3658CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3658CTIDB
  • View Report: Research and Experts Market Report: Idiopathic (Essential) Hypertension - Pipeline Review, H2 2016

    Idiopathic (Essential) Hypertension - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H2 2016’, provides an overview of the Idiopathic (Essential) Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8388IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8388IDB
  • View Report: Research and Experts Market Report: Anal Cancer - Pipeline Review, H2 2016

    Anal Cancer - Pipeline Review, H2 2016


    2016-08-17
    Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H2 2016’, provides an overview of the Anal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anal Cancer, complete...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8370IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8370IDB
  • View Report: Research and Experts Market Report: Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2016

    Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2016’, provides in depth analysis on Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0456TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0456TDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H2 2016’, provides an overview of the Alzheimer's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8356IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8356IDB
  • View Report: Research and Experts Market Report: Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016

    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Renal Cell Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8355IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8355IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016’, provides an overview of the Crohn's Disease (Regional Enteritis) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8354IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8354IDB
  • View Report: Research and Experts Market Report: Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2016

    Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2016’, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8353IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8353IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2016

    Mantle Cell Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Mantle...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8348IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8348IDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy - Pipeline Review, H2 2016

    Diabetic Nephropathy - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H2 2016’, provides an overview of the Diabetic Nephropathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8347IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8347IDB
  • View Report: Research and Experts Market Report: Dementia - Pipeline Review, H2 2016

    Dementia - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Dementia - Pipeline Review, H2 2016’, provides an overview of the Dementia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dementia, complete with analysis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8345IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8345IDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis - Pipeline Review, H2 2016

    Atopic Dermatitis - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Atopic Dermatitis - Pipeline Review, H2 2016’, provides an overview of the Atopic Dermatitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Atopic...

  • Market Report
  • Dermatology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8341IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8341IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H2 2016

    Indolent Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Indolent Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Indolent...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8340IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8340IDB
  • View Report: Research and Experts Market Report: Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2016

    Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2016" provides an overview of Pulmonary Arterial Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3610CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3610CTIDB
  • View Report: Research and Experts Market Report: Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2016

    Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral Artery Occlusive Disease (PAOD) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3603CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3603CTIDB
  • View Report: Research and Experts Market Report: Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016

    Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016" provides an overview of Occlusive Coronary Artery Disease clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3602CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3602CTIDB
  • View Report: Research and Experts Market Report: Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2016

    Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2016" provides an overview of Occlusive Arterial Disease (OAD) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3601CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3601CTIDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2016

    Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2016" provides an overview of Idiopathic Pulmonary Hypertension clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3596CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3596CTIDB
  • View Report: Research and Experts Market Report: Arterial Stiffness Global Clinical Trials Review, H2, 2016

    Arterial Stiffness Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Arterial Stiffness Global Clinical Trials Review, H2, 2016" provides an overview of Arterial Stiffness clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Stiffness....
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3589CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3589CTIDB
  • View Report: Research and Experts Market Report: Atherosclerosis Global Clinical Trials Review, H2, 2016

    Atherosclerosis Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Atherosclerosis Global Clinical Trials Review, H2, 2016" provides an overview of Atherosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Atherosclerosis. Report...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3587CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3587CTIDB
  • View Report: Research and Experts Market Report: Arteriosclerosis Global Clinical Trials Review, H2, 2016

    Arteriosclerosis Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Arteriosclerosis Global Clinical Trials Review, H2, 2016" provides an overview of Arteriosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriosclerosis. Report...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3583CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3583CTIDB
  • View Report: Research and Experts Market Report: Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016

    Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016" provides an overview of Social Anxiety Disorders (SAD) clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3579CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3579CTIDB
  • View Report: Research and Experts Market Report: Trichotillomania Global Clinical Trials Review, H2, 2016

    Trichotillomania Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Trichotillomania Global Clinical Trials Review, H2, 2016" provides an overview of Trichotillomania clinical trials scenario. This report provides top line data relating to the clinical trials on Trichotillomania. Report...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3577CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3577CTIDB
  • View Report: Research and Experts Market Report: Schizoaffective Disorder Global Clinical Trials Review, H2, 2016

    Schizoaffective Disorder Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Schizoaffective Disorder Global Clinical Trials Review, H2, 2016" provides an overview of Schizoaffective Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Schizoaffective...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3574CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3574CTIDB
  • View Report: Research and Experts Market Report: Spinal Stenosis Global Clinical Trials Review, H2, 2016

    Spinal Stenosis Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Spinal Stenosis Global Clinical Trials Review, H2, 2016" provides an overview of Spinal Stenosis clinical trials scenario. This report provides top line data relating to the clinical trials on Spinal Stenosis. Report...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3563CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3563CTIDB
  • View Report: Research and Experts Market Report: Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2016

    Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2016" provides an overview of Oppositional Defiant Disorder (ODD) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3557CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3557CTIDB
  • View Report: Research and Experts Market Report: Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2016

    Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3555CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3555CTIDB
  • View Report: Research and Experts Market Report: Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2016

    Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2016" provides an overview of Obsessive-Compulsive Disorder clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3552CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3552CTIDB
  • View Report: Research and Experts Market Report: Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase...

    Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H2 2016


    2016-07-27
    ‘Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H2 2016’, provides in depth analysis on Nitric Oxide Synthase...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0415TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0415TDB
  • View Report: Research and Experts Market Report: Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4...

    Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR or CDK9 or EC 2.7.11.22 or EC 2.7.11.23) - Pipeli


    2016-07-27
    ‘Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR or CDK9 or EC 2.7.11.22 or EC 2.7.11.23)...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0414TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0414TDB
  • View Report: Research and Experts Market Report: Angiopoietin 2 (Ang 2 or ANGPT2) - Pipeline Review, H2 2016

    Angiopoietin 2 (Ang 2 or ANGPT2) - Pipeline Review, H2 2016


    2016-07-27
    ‘Angiopoietin 2 (Ang 2 or ANGPT2) - Pipeline Review, H2 2016’, provides in depth analysis on Angiopoietin 2 (Ang 2 or ANGPT2) targeted pipeline therapeutics.

    The report provides comprehensive information on the Angiopoietin 2 (Ang 2 or ANGPT2),...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0411TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0411TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2016

    Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0400TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0400TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2016

    Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0399TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0399TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016

    Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-07-20
    ‘Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0398TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0398TDB
  • View Report: Research and Experts Market Report: Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H2 2016

    Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H2 2016


    2016-07-20
    ‘Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H2 2016’, provides in depth analysis on Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22)...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0394TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0394TDB
  • View Report: Research and Experts Market Report: Hypoglycemia - Pipeline Review, H2 2016

    Hypoglycemia - Pipeline Review, H2 2016


    2016-07-20
    ‘Hypoglycemia - Pipeline Review, H2 2016’, provides an overview of the Hypoglycemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypoglycemia, complete with analysis by stage of...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8287IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8287IDB
  • View Report: Research and Experts Market Report: Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016

    Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016


    2016-07-20
    ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016’, provides an overview of the Non-Alcoholic Steatohepatitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Alcoholic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8327IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8327IDB
  • View Report: Research and Experts Market Report: Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2016

    Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2016


    2016-07-27
    ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2016’, provides an overview of the Post-Traumatic Stress Disorder (PTSD) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8308IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8308IDB
  • View Report: Research and Experts Market Report: Alcohol Addiction - Pipeline Review, H2 2016

    Alcohol Addiction - Pipeline Review, H2 2016


    2016-07-20
    ‘Alcohol Addiction - Pipeline Review, H2 2016’, provides an overview of the Alcohol Addiction pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Alcohol Addiction, complete with analysis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8298IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8298IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016


    2016-07-20
    ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8297IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8297IDB
  • View Report: Research and Experts Market Report: TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Pipeline Review, H2 2016

    TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Pipeline Review, H2 2016’, provides in depth analysis on TGF Beta Receptor Type 2 (Transforming Growth Factor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0387TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0387TDB
  • View Report: Research and Experts Market Report: Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline...

    Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Macrophage Colony Stimulating...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0386TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0386TDB
  • View Report: Research and Experts Market Report: Acute Heart Failure - Pipeline Review, H2 2016

    Acute Heart Failure - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Acute Heart Failure - Pipeline Review, H2 2016’, provides an overview of the Acute Heart Failure pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Acute...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8234IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8234IDB
  • View Report: Research and Experts Market Report: Japanese Encephalitis Global Clinical Trials Review, H1, 2016

    Japanese Encephalitis Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Japanese Encephalitis Global Clinical Trials Review, H1, 2016" provides an overview of Japanese Encephalitis clinical trials scenario. This report provides top line data relating to the clinical trials on Japanese Encephalitis...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3531CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3531CTIDB
  • View Report: Research and Experts Market Report: Neuropathic Pain Global Clinical Trials Review, H1, 2016

    Neuropathic Pain Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Neuropathic Pain Global Clinical Trials Review, H1, 2016" provides an overview of Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Neuropathic Pain. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3528CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3528CTIDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment Global Clinical Trials Review, H1, 2016

    Mild Cognitive Impairment Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Mild Cognitive Impairment Global Clinical Trials Review, H1, 2016" provides an overview of Mild Cognitive Impairment clinical trials scenario. This report provides top line data relating to the clinical trials on Mild...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3523CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3523CTIDB
  • View Report: Research and Experts Market Report: Dementia Associated With Alzheimer

    Dementia Associated With Alzheimer's Disease Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Dementia Associated With Alzheimer's Disease Global Clinical Trials Review, H1, 2016" provides an overview of Dementia Associated With Alzheimer's Disease clinical trials scenario. This report provides top line...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3521CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3521CTIDB
  • View Report: Research and Experts Market Report: MAP Kinase-Interacting Serine/Threonine-Protein Kinase 2 (Mitogen Activated Protein Kinase-Interacting Kinase 2 or MAP Kinase Signal-Integrating...

    MAP Kinase-Interacting Serine/Threonine-Protein Kinase 2 (Mitogen Activated Protein Kinase-Interacting Kinase 2 or MAP Kinase Signal-Integrating Kinase 2 or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘MAP Kinase-Interacting Serine/Threonine-Protein Kinase 2 (Mitogen Activated Protein Kinase-Interacting Kinase 2 or MAP Kinase Signal-Integrating Kinase 2 or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0342TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0342TDB
  • View Report: Research and Experts Market Report: MAP Kinase-Interacting Serine/Threonine-Protein Kinase 1 (Mitogen Activated Protein Kinase-Interacting Kinase 1 or MAP Kinase Signal-Integrating...

    MAP Kinase-Interacting Serine/Threonine-Protein Kinase 1 (Mitogen Activated Protein Kinase-Interacting Kinase 1 or MAP Kinase Signal-Integrating Kinase 1 or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘MAP Kinase-Interacting Serine/Threonine-Protein Kinase 1 (Mitogen Activated Protein Kinase-Interacting Kinase 1 or MAP Kinase Signal-Integrating Kinase 1 or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0341TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0341TDB
  • View Report: Research and Experts Market Report: Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016

    Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) targeted pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0228TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0228TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0225TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0225TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0224TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0224TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0223TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0223TDB
  • View Report: Research and Experts Market Report: Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or EC 2.7.11.1) - Pipeline Review, H1 2016

    Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0215TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0215TDB
  • View Report: Research and Experts Market Report: Cyclin-Dependent Kinase 6 (Cell Division Protein Kinase 6 or EC 2.7.11.22) - Pipeline Review, H1 2016

    Cyclin-Dependent Kinase 6 (Cell Division Protein Kinase 6 or EC 2.7.11.22) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Cyclin-Dependent Kinase 6 (Cell Division Protein Kinase 6 or EC 2.7.11.22) - Pipeline Review, H1 2016’, provides in depth analysis on Cyclin-Dependent Kinase 6 (Cell Division Protein Kinase 6 or EC 2.7.11.22) targeted...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0209TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0209TDB
  • View Report: Research and Experts Market Report: RAF Proto-Oncogene Serine/Threonine-Protein Kinase (C-Raf Kinase or Proto-Oncogene c-RAF or Raf-1 or EC 2.7.11.1) - Pipeline Review,...

    RAF Proto-Oncogene Serine/Threonine-Protein Kinase (C-Raf Kinase or Proto-Oncogene c-RAF or Raf-1 or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘RAF Proto-Oncogene Serine/Threonine-Protein Kinase (C-Raf Kinase or Proto-Oncogene c-RAF or Raf-1 or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on RAF Proto-Oncogene Serine/Threonine-Protein...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0205TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0205TDB
  • View Report: Research and Experts Market Report: Serine/Threonine-Protein Kinase A-Raf (A-Raf Kinase or Proto-Oncogene A-Raf or Proto-Oncogene Pks or EC 2.7.11.1) - Pipeline Review,...

    Serine/Threonine-Protein Kinase A-Raf (A-Raf Kinase or Proto-Oncogene A-Raf or Proto-Oncogene Pks or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Serine/Threonine-Protein Kinase A-Raf (A-Raf Kinase or Proto-Oncogene A-Raf or Proto-Oncogene Pks or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on Serine/Threonine-Protein Kinase A-Raf...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0204TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0204TDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7960IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7960IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2016

    Colorectal Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colorectal...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7959IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7959IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2016

    Melanoma - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2016’, provides an overview of the Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7955IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7955IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2016

    Breast Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Breast Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7666IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7666IDB
  • View Report: Research and Experts Market Report: Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016

    Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016" provides an overview of Glucocorticoid-Induced Osteoporosis clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3508CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3508CTIDB
  • View Report: Research and Experts Market Report: Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2016

    Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Peripheral Neuropathy clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3503CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3503CTIDB
  • View Report: Research and Experts Company Report: Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review

    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review


    2016-08-02
    Johnson & Johnson (J&J) is a holding company that manufactures and sells a broad range of products in pharmaceutical, consumer and medical fields. Its product offerings include drugs to treat immune disorders, neurological diseases, cancer, cardio...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH659FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH659FSA
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2016

    Neuropathic Pain - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Neuropathic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7966IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7966IDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2016’, provides an overview of the Parkinson's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7961IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7961IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2016

    Rheumatoid Arthritis - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2016’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rheumatoid...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7957IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7957IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2016

    Ovarian Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ovarian Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7956IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7956IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7954IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7954IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2016

    Pancreatic Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pancreatic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7953IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7953IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2016

    Prostate Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Prostate Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7952IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7952IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016

    Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Small-Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3500CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3500CTIDB
  • View Report: Research and Experts Market Report: Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016

    Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016" provides an overview of Adrenocortical Carcinoma (Adrenal Cortex Cancer) clinical trials scenario. This report...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3493CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3493CTIDB
  • View Report: Research and Experts Market Report: Malignant Mesothelioma Global Clinical Trials Review, H1, 2016

    Malignant Mesothelioma Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H1, 2016" provides an overview of Malignant Mesothelioma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3489CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3489CTIDB
  • View Report: Research and Experts Market Report: Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

    Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016’, provides in depth analysis on Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) targeted...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0269TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0269TDB
  • View Report: Research and Experts Market Report: Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC...

    Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016’, provides in depth analysis on Proprotein Convertase...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0250TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0250TDB
  • View Report: Research and Experts Market Report: Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H1 2016

    Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H1 2016’, provides in depth analysis on Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0094TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0094TDB
  • View Report: Research and Experts Market Report: Metabotropic Glutamate Receptor 2 (mGluR2 or GRM2 or GPRC1B or MGLUR2) - Pipeline Review, H1 2016

    Metabotropic Glutamate Receptor 2 (mGluR2 or GRM2 or GPRC1B or MGLUR2) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 2 (mGluR2 or GRM2 or GPRC1B or MGLUR2) - Pipeline Review, H1 2016’, provides in depth analysis on Metabotropic Glutamate Receptor 2 (mGluR2 or GRM2 or GPRC1B or MGLUR2) targeted...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0089TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0089TDB
  • View Report: Research and Experts Market Report: C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated...

    C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0085TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0085TDB
  • View Report: Research and Experts Market Report: Growth/Differentiation Factor 8 (Myostatin or GDF-8) - Pipeline Review, H1 2016

    Growth/Differentiation Factor 8 (Myostatin or GDF-8) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Growth/Differentiation Factor 8 (Myostatin or GDF-8) - Pipeline Review, H1 2016’, provides in depth analysis on Growth/Differentiation Factor 8 (Myostatin or GDF-8) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0052TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0052TDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2016

    Liver Cancer - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Liver Cancer, complete...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7964IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7964IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7963IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7963IDB
  • View Report: Research and Experts Market Report: Gastric and Gastroesophageal Junction Adenocarcinoma - Current and Future Players

    Gastric and Gastroesophageal Junction Adenocarcinoma - Current and Future Players


    2015-12-09
    GlobalData has released its pharma report, “Gastric and Gastroesophageal Junction Adenocarcinoma - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing...
  • Market Report
  • Life Sciences
  • Global
  • $2,995.00
  • Report 05IC-GDHC1047FPR has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC1047FPR
  • View Report: Research and Experts Market Report: Psoriasis - Current and Future Players

    Psoriasis - Current and Future Players


    2016-04-13
    GlobalData has released its pharma report, “Psoriasis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Psoriasis Market. The report identifies...
  • Market Report
  • Life Sciences
  • Global
  • $2,995.00
  • Report 05IC-GDHC1044FPR has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC1044FPR
  • View Report: Research and Experts Market Report: Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016

    Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016


    2016-07-04
    GlobalData's Medical Devices sector report, “Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016" provides an overview of Drug Delivery Infusion Systems currently in pipeline stage.

    The report provides comprehensive...

  • Market Report
  • Medical Devices
  • Global
  • $4,000.00
  • Report 05IC-GDME0209EPD has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDME0209EPD
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Hormone Refractory (Castration Resistant, Androgen-Independent)...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3478CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3478CTIDB
  • View Report: Research and Experts Market Report: High-Grade Glioma Global Clinical Trials Review, H1, 2016

    High-Grade Glioma Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “High-Grade Glioma Global Clinical Trials Review, H1, 2016" provides an overview of High-Grade Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on High-Grade...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3476CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3476CTIDB
  • View Report: Research and Experts Market Report: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2016

    Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2016" provides an overview of Choriocarcinoma (Gestational Trophoblastic Neoplasia) clinical trials scenario....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3472CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3472CTIDB
  • View Report: Research and Experts Market Report: Brenner Tumor Global Clinical Trials Review, H1, 2016

    Brenner Tumor Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Brenner Tumor Global Clinical Trials Review, H1, 2016" provides an overview of Brenner Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Brenner Tumor....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3471CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3471CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024

    PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024


    2016-04-13
    Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC119PIDR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC119PIDR
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016

    Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) clinical trials scenario. This report provides top line data...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3449CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3449CTIDB
  • View Report: Research and Experts Market Report: Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2016

    Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2016" provides an overview of Basal Cell Carcinoma (Basal Cell Epithelioma) clinical trials scenario. This report provides...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3448CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3448CTIDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016

    Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016" provides an overview of Hepatocellular Carcinoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3446CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3446CTIDB
  • View Report: Research and Experts Market Report: Hypoglycemia Global Clinical Trials Review, H1, 2016

    Hypoglycemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hypoglycemia Global Clinical Trials Review, H1, 2016" provides an overview of Hypoglycemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypoglycemia....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3438CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3438CTIDB
  • View Report: Research and Experts Market Report: Diabetic Retinopathy Global Clinical Trials Review, H1, 2016

    Diabetic Retinopathy Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diabetic Retinopathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Retinopathy clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3437CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3437CTIDB
  • View Report: Research and Experts Market Report: Hyperglycemia Global Clinical Trials Review, H1, 2016

    Hyperglycemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hyperglycemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperglycemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperglycemia....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3435CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3435CTIDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathy Global Clinical Trials Review, H1, 2016

    Diabetic Neuropathy Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diabetic Neuropathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Neuropathy clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3434CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3434CTIDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy Global Clinical Trials Review, H1, 2016

    Diabetic Nephropathy Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3433CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3433CTIDB
  • View Report: Research and Experts Market Report: Acute Lung Injury Global Clinical Trials Review, H1, 2016

    Acute Lung Injury Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Acute Lung Injury Global Clinical Trials Review, H1, 2016" provides an overview of Acute Lung Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Acute...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3426CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3426CTIDB
  • View Report: Research and Experts Market Report: Wilms

    Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2016" provides an overview of Wilms' Tumor (Nephroblastoma) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3420CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3420CTIDB
  • View Report: Research and Experts Market Report: Oligodendroglioma Global Clinical Trials Review, H1, 2016

    Oligodendroglioma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, H1, 2016" provides an overview of Oligodendroglioma clinical trials scenario. This report provides top line data relating to the clinical trials on Oligodendro...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3419CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3419CTIDB
  • View Report: Research and Experts Market Report: Rhabdomyosarcoma Global Clinical Trials Review, H1, 2016

    Rhabdomyosarcoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Rhabdomyosarcoma Global Clinical Trials Review, H1, 2016" provides an overview of Rhabdomyosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Rhabdomyosarc...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3416CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3416CTIDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer Global Clinical Trials Review, H1, 2016

    Pancreatic Cancer Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3415CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3415CTIDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Global Clinical Trials Review, H1, 2016

    Head And Neck Cancer Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Head And Neck Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Head And Neck Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3413CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3413CTIDB
  • View Report: Research and Experts Market Report: Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2016

    Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2016" provides an overview of Anaplastic Astrocytoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3412CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3412CTIDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2016

    Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2016" provides an overview of Glioblastoma Multiforme (GBM) clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3411CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3411CTIDB
  • View Report: Research and Experts Market Report: Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) - Pipeline Review, H1 2016

    Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) - Pipeline Review, H1 2016’, provides in depth analysis on Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) targeted...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0088TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0088TDB
  • View Report: Research and Experts Market Report: Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016

    Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016’, provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8171IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8171IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8160IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8160IDB
  • View Report: Research and Experts Market Report: Colon Cancer - Pipeline Review, H1 2016

    Colon Cancer - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2016’, provides an overview of the Colon Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colon Cancer, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7965IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7965IDB
  • View Report: Research and Experts Market Report: Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016

    Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016’, provides an overview of the Sicca Syndrome (Sjogren) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8187IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8187IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8167IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8167IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8161IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8161IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H1 2016

    Hypertension - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2016’, provides an overview of the Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypertension, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7972IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7972IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2016

    Metastatic Breast Cancer - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7968IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7968IDB
  • View Report: Research and Experts Market Report: Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

    Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7967IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7967IDB
  • View Report: Research and Experts Market Report: Axial Spondyloarthritis - Pipeline Review, H1 2016

    Axial Spondyloarthritis - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Axial Spondyloarthritis - Pipeline Review, H1 2016’, provides an overview of the Axial Spondyloarthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8142IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8142IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2016

    Schizophrenia - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2016’, provides an overview of the Schizophrenia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Schizophrenia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8107IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8107IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7977IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7977IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2016

    Hepatocellular Carcinoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Hepatocellular Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7971IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7971IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Hodgkin...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7970IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7970IDB
  • View Report: Research and Experts Company Report: Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review

    Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review


    2016-06-01
    Alkermes Plc (Alkermes) is a biotechnology company which research, develops and commercializes drugs for the treatment of central nervous system (CNS) diseases. It has commercial products portfolio that includes schizophrenia, depression, addiction and...
  • Company Report
  • Life Sciences
  • Ireland
  • $125.00
  • Report 05IC-GDPH5650FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH5650FSA
  • View Report: Research and Experts Market Report: Ewing Sarcoma Global Clinical Trials Review, H1, 2016

    Ewing Sarcoma Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Ewing Sarcoma Global Clinical Trials Review, H1, 2016" provides an overview of Ewing Sarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3409CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3409CTIDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016

    Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Fallopian Tube Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3407CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3407CTIDB
  • View Report: Research and Experts Market Report: Gallbladder Cancer Global Clinical Trials Review, H1, 2016

    Gallbladder Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Gallbladder Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Gallbladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3406CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3406CTIDB
  • View Report: Research and Experts Market Report: Esophageal Cancer Global Clinical Trials Review, H1, 2016

    Esophageal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Esophageal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Esophageal...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3405CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3405CTIDB
  • View Report: Research and Experts Market Report: Ovarian Cancer Global Clinical Trials Review, H1, 2016

    Ovarian Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3404CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3404CTIDB
  • View Report: Research and Experts Market Report: Uterine Cancer Global Clinical Trials Review, H1, 2016

    Uterine Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Uterine Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Uterine Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Uterine...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3403CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3403CTIDB
  • View Report: Research and Experts Market Report: Gastric Cancer Global Clinical Trials Review, H1, 2016

    Gastric Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Gastric Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Gastric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Gastric...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3402CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3402CTIDB
  • View Report: Research and Experts Market Report: Cervical Cancer Global Clinical Trials Review, H1, 2016

    Cervical Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Cervical Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Cervical Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3401CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3401CTIDB
  • View Report: Research and Experts Market Report: Peritoneal Cancer Global Clinical Trials Review, H1, 2016

    Peritoneal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Peritoneal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Peritoneal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Peritoneal...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3400CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3400CTIDB
  • View Report: Research and Experts Market Report: Thymus Cancer Global Clinical Trials Review, H1, 2016

    Thymus Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Thymus Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Thymus Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Thymus Cancer....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3393CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3393CTIDB
  • View Report: Research and Experts Market Report: Diabetic Gastroparesis Global Clinical Trials Review, H1, 2016

    Diabetic Gastroparesis Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Diabetic Gastroparesis Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3390CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3390CTIDB
  • View Report: Research and Experts Market Report: Bipolar Disorder - Current and Future Players

    Bipolar Disorder - Current and Future Players


    2016-03-01
    GlobalData has released its pharma report, “Bipolar Disorder - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Bipolar Disorder Market. The report...
  • Market Report
  • Life Sciences
  • Global
  • $2,995.00
  • Report 05IC-GDHC1043FPR has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC1043FPR
  • View Report: Research and Experts Market Report: Hypercholesterolemia - Pipeline Review, H1 2016

    Hypercholesterolemia - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Hypercholesterolemia - Pipeline Review, H1 2016’, provides an overview of the Hypercholesterolemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypercholesterolemia...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8007IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8007IDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H1 2016

    Migraine - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2016’, provides an overview of the Migraine pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Migraine, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8006IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8006IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent)...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8003IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8003IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H1 2016

    Epithelial Ovarian Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Epithelial Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8000IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8000IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2016

    Small-Cell Lung Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Small-Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7991IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7991IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2016

    Metastatic Colorectal Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7985IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7985IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2016

    Myelodysplastic Syndrome - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2016’, provides an overview of the Myelodysplastic Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7984IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7984IDB
  • View Report: Research and Experts Market Report: Malignant Pleural Mesothelioma - Pipeline Review, H1 2016

    Malignant Pleural Mesothelioma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Malignant Pleural Mesothelioma - Pipeline Review, H1 2016’, provides an overview of the Malignant Pleural Mesothelioma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8025IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8025IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016’, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8024IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8024IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H1 2016

    Endometrial Cancer - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H1 2016’, provides an overview of the Endometrial Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Endometrial...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8014IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8014IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H1 2016

    Psoriatic Arthritis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2016’, provides an overview of the Psoriatic Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriatic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8010IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8010IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2016

    Renal Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Renal Cell Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Renal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7981IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7981IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H1 2016

    Tuberculosis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2016’, provides an overview of the Tuberculosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Tuberculosis, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7976IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7976IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2016

    Systemic Lupus Erythematosus - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2016’, provides an overview of the Systemic Lupus Erythematosus pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7998IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7998IDB
  • View Report: Research and Experts Market Report: Osteoporosis - Pipeline Review, H1 2016

    Osteoporosis - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Osteoporosis - Pipeline Review, H1 2016’, provides an overview of the Osteoporosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoporosis, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7989IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7989IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7988IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7988IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7978IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7978IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7687IDB
  • View Report: Research and Experts Market Report: Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2016

    Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2016


    2016-06-01
    GlobalData's Medical Devices sector report, “Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2016" provides an overview of Implantable Infusion Pumps currently in pipeline stage.

    The report provides comprehensive information...

  • Market Report
  • Medical Devices
  • Global
  • $2,500.00
  • Report 05IC-GDME0195EPD has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDME0195EPD
  • View Report: Research and Experts Market Report: Osteosarcoma Global Clinical Trials Review, H1, 2016

    Osteosarcoma Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Osteosarcoma Global Clinical Trials Review, H1, 2016" provides an overview of Osteosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Osteosarcoma....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3389CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3389CTIDB
  • View Report: Research and Experts Market Report: Myelofibrosis Global Clinical Trials Review, H1, 2016

    Myelofibrosis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H1, 2016" provides an overview of Myelofibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Myelofibrosis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3385CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3385CTIDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis Global Clinical Trials Review, H1, 2016

    Psoriatic Arthritis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Psoriatic Arthritis Global Clinical Trials Review, H1, 2016" provides an overview of Psoriatic Arthritis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3384CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3384CTIDB
  • View Report: Research and Experts Market Report: Sickle Cell Disease Global Clinical Trials Review, H1, 2016

    Sickle Cell Disease Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Sickle Cell Disease Global Clinical Trials Review, H1, 2016" provides an overview of Sickle Cell Disease clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3380CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3380CTIDB
  • View Report: Research and Experts Market Report: Osteopenia Global Clinical Trials Review, H1, 2016

    Osteopenia Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Osteopenia Global Clinical Trials Review, H1, 2016" provides an overview of Osteopenia clinical trials scenario. This report provides top line data relating to the clinical trials on Osteopenia. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3379CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3379CTIDB
  • View Report: Research and Experts Market Report: Osteoporosis Global Clinical Trials Review, H1, 2016

    Osteoporosis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Osteoporosis Global Clinical Trials Review, H1, 2016" provides an overview of Osteoporosis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoporosis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3378CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3378CTIDB
  • View Report: Research and Experts Market Report: Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016

    Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016" provides an overview of Interstitial Cystitis (Painful Bladder Syndrome) clinical trials scenario. This report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3374CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3374CTIDB
  • View Report: Research and Experts Market Report: Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016

    Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016’, provides in depth analysis on Calcitonin Gene Related Peptide (CGRP) targeted pipeline therapeutics.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0013TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0013TDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2016

    Obesity - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2016’, provides an overview of the Obesity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Obesity, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7684IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7684IDB
  • View Report: Research and Experts Market Report: PharmaPoint: Bipolar Disorder - Global Drug Forecast and Market Analysis to 2024

    PharmaPoint: Bipolar Disorder - Global Drug Forecast and Market Analysis to 2024


    2016-03-01
    Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC124PIDR has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC124PIDR
  • View Report: Research and Experts Market Report: Peripheral Neuropathic Pain - Pipeline Review, H1 2016

    Peripheral Neuropathic Pain - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Peripheral Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Peripheral Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7888IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7888IDB
  • View Report: Research and Experts Market Report: Post Menopausal Osteoporosis - Pipeline Review, H1 2016

    Post Menopausal Osteoporosis - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Pipeline Review, H1 2016’, provides an overview of the Post Menopausal Osteoporosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7873IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7873IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H1 2016

    Osteoarthritis Pain - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7825IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7825IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H1 2016

    Fallopian Tube Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H1 2016’, provides an overview of the Fallopian Tube Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7816IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7816IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2016

    Gastric Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2016’, provides an overview of the Gastric Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastric Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7815IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7815IDB
  • View Report: Research and Experts Market Report: Head and neck Cancer - Pipeline Review, H1 2016

    Head and neck Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Head...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7685IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7685IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2016

    Type 2 Diabetes - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2016’, provides an overview of the Type 2 Diabetes pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Type 2 Diabetes,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7682IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7682IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H1 2016

    Ulcerative Colitis - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2016’, provides an overview of the Ulcerative Colitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ulcerative...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7601IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7601IDB
  • View Report: Research and Experts Market Report: Biliary Cirrhosis Global Clinical Trials Review, H1, 2016

    Biliary Cirrhosis Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Biliary Cirrhosis Global Clinical Trials Review, H1, 2016" provides an overview of Biliary Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical trials on Biliary...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3364CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3364CTIDB
  • View Report: Research and Experts Market Report: Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2016

    Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Adult Respiratory Distress Syndrome clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3358CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3358CTIDB
  • View Report: Research and Experts Market Report: Septic Shock Global Clinical Trials Review, H1, 2016

    Septic Shock Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Septic Shock Global Clinical Trials Review, H1, 2016" provides an overview of Septic Shock clinical trials scenario. This report provides top line data relating to the clinical trials on Septic Shock....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3348CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3348CTIDB
  • View Report: Research and Experts Market Report: Metastatic Ovarian Cancer - Pipeline Review, H1 2016

    Metastatic Ovarian Cancer - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7892IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7892IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H1 2016

    Mild Cognitive Impairment - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Mild Cognitive Impairment - Pipeline Review, H1 2016’, provides an overview of the Mild Cognitive Impairment pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7841IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7841IDB
  • View Report: Research and Experts Market Report: Major Depressive Disorder - Pipeline Review, H1 2016

    Major Depressive Disorder - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Major Depressive Disorder - Pipeline Review, H1 2016’, provides an overview of the Major Depressive Disorder pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7826IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7826IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7822IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7822IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7817IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7817IDB
  • View Report: Research and Experts Market Report: Uveal Melanoma - Pipeline Review, H1 2016

    Uveal Melanoma - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Uveal Melanoma - Pipeline Review, H1 2016’, provides an overview of the Uveal Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Uveal Melanoma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7864IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7864IDB
  • View Report: Research and Experts Market Report: Fragile X Syndrome - Pipeline Review, H1 2016

    Fragile X Syndrome - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Fragile X Syndrome - Pipeline Review, H1 2016’, provides an overview of the Fragile X Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Fragile...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7859IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7859IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H1 2016

    Metastatic Melanoma - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2016’, provides an overview of the Metastatic Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Metastatic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7691IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7691IDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H1 2016

    Chronic Pain - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H1 2016’, provides an overview of the Chronic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Chronic Pain, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7690IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7690IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7689IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7689IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2016

    Psoriasis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7686IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7686IDB
  • View Report: Research and Experts Market Report: Metastatic Pancreatic Cancer - Pipeline Review, H1 2016

    Metastatic Pancreatic Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7699IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7699IDB
  • View Report: Research and Experts Market Report: Peritoneal Cancer - Pipeline Review, H1 2016

    Peritoneal Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2016’, provides an overview of the Peritoneal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Peritoneal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7697IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7697IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2016

    Cognitive Impairment - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cognitive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7696IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7696IDB
  • View Report: Research and Experts Market Report: Depression - Pipeline Review, H1 2016

    Depression - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2016’, provides an overview of the Depression pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Depression, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7581IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7581IDB
  • View Report: Research and Experts Market Report: Pulmonary Arterial Hypertension - Pipeline Review, H1 2016

    Pulmonary Arterial Hypertension - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Pulmonary Arterial Hypertension - Pipeline Review, H1 2016’, provides an overview of the Pulmonary Arterial Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7707IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7707IDB
  • View Report: Research and Experts Market Report: Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2016

    Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2016’, provides an overview of the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) pipeline landscape.

    The...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7705IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7705IDB
  • View Report: Research and Experts Market Report: Anxiety Disorders - Pipeline Review, H1 2016

    Anxiety Disorders - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H1 2016’, provides an overview of the Anxiety Disorders pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anxiety...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7698IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7698IDB
  • View Report: Research and Experts Market Report: Male Hypogonadism Global Clinical Trials Review, H1, 2016

    Male Hypogonadism Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Male Hypogonadism Global Clinical Trials Review, H1, 2016" provides an overview of Male Hypogonadism clinical trials scenario. This report provides top line data relating to the clinical trials on Male...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3324CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3324CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Head and Neck Squamous Cell Carcinoma - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Head and Neck Squamous Cell Carcinoma - Opportunity Analysis and Forecast to 2024


    2016-02-02
    The head and neck cancer (HNC) market is one currently dominated by generic chemotherapies, with little competition from branded therapies. The market landscape is set to undergo substantial growth between 2014 and 2024. The main drivers of growth will...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC054POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC054POA
  • View Report: Research and Experts Market Report: Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2016

    Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2016" provides an overview of Attention Deficit Hyperactivity Disorder (ADHD) clinical trials scenario. This report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3312CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3312CTIDB
  • View Report: Research and Experts Market Report: Gestational Diabetes Global Clinical Trials Review, H1, 2016

    Gestational Diabetes Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Gestational Diabetes Global Clinical Trials Review, H1, 2016" provides an overview of Gestational Diabetes clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3308CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3308CTIDB
  • View Report: Research and Experts Market Report: Hyperalgesia Global Clinical Trials Review, H1, 2016

    Hyperalgesia Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Hyperalgesia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperalgesia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperalgesia....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3307CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3307CTIDB
  • View Report: Research and Experts Industry Report: Eli Lilly and Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

    Eli Lilly and Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report


    2016-06-30
    Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive...
  • Industry Report
  • Pharmaceuticals
  • United States
  • $350.00
  • Report 05IK-B90AC614-8DEA-40ED-8EFE-1C has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-B90AC614-8DEA-40ED-8EFE-1C
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H1 2016

    Osteoarthritis - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7811IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7811IDB
  • View Report: Research and Experts Market Report: Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016

    Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016’, provides an overview of the Idiopathic (Essential) Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7744IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7744IDB
  • View Report: Research and Experts Market Report: Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016

    Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016’, provides an overview of the Metastatic Hepatocellular Carcinoma (HCC) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7726IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7726IDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H1 2016

    Dyslipidemia - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H1 2016’, provides an overview of the Dyslipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dyslipidemia, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7652IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7652IDB
  • View Report: Research and Experts Market Report: Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016

    Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016" provides an overview of Peripheral Neuropathy (Sensory Neuropathy) clinical trials scenario. This report provides top...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3299CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3299CTIDB
  • View Report: Research and Experts Market Report: Cluster Headache Syndrome Global Clinical Trials Review, H1, 2016

    Cluster Headache Syndrome Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Cluster Headache Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Cluster Headache Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3294CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3294CTIDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain Global Clinical Trials Review, H1, 2016

    Osteoarthritis Pain Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Osteoarthritis Pain Global Clinical Trials Review, H1, 2016" provides an overview of Osteoarthritis Pain clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3293CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3293CTIDB
  • View Report: Research and Experts Market Report: Anorexia Nervosa Global Clinical Trials Review, H1, 2016

    Anorexia Nervosa Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Anorexia Nervosa Global Clinical Trials Review, H1, 2016" provides an overview of Anorexia Nervosa clinical trials scenario. This report provides top line data relating to the clinical trials on Anorexia...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3289CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3289CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Pulmonary Arterial Hypertension - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Pulmonary Arterial Hypertension - Opportunity Analysis and Forecast to 2024


    2016-01-01
    GlobalData estimates the 2014 sales for pulmonary arterial hypertension (PAH) at approximately $3.45 billion across the 7MM covered in this report, which include the US, 5EU and Japan. The market will grow moderately at a CAGR of 3.20% during the 10-year...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC050POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC050POA
  • View Report: Research and Experts Market Report: Anal Cancer - Pipeline Review, H1 2016

    Anal Cancer - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H1 2016’, provides an overview of the Anal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anal Cancer, complete...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7766IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7766IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Alzheimer’s Disease - Pipeline Review, H1 2016’, provides an overview of the Alzheimer’s Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7570IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7570IDB
  • View Report: Research and Experts Market Report: Dental Pain Global Clinical Trials Review, H1, 2016

    Dental Pain Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Dental Pain Global Clinical Trials Review, H1, 2016" provides an overview of Dental Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Dental Pain. Report...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3261CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3261CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024


    2016-01-01
    Vasculitis is a family of rare autoimmune diseases, causing inflammation of the blood vessels, arteries, veins or capillaries. The different forms of vasculitis are classified by the size and location of the affected blood vessels . This report specifical...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC045POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC045POA
  • View Report: Research and Experts Company Report: F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile

    F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company. It is one of the leading providers of biopharmaceuticals, cancer medicines and in vitro diagnostics (IVD) systems. Its major products include medicines to treat cancers, brain...
  • Company Report
  • Medical Devices
  • Switzerland
  • $250.00
  • Report 05IB-GDME756D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME756D
  • View Report: Research and Experts Company Report: Novo Nordisk AS (NOVO B) - Medical Equipment - Deals and Alliances Profile

    Novo Nordisk AS (NOVO B) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Novo Nordisk A/S (Novo Nordisk) is a healthcare company that discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disor...
  • Company Report
  • Medical Devices
  • Denmark
  • $250.00
  • Report 05IB-GDME7427D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME7427D
  • View Report: Research and Experts Company Report: Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile

    Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Johnson & Johnson (J&J) is a pharmaceutical holding company. It carries out the manufacture and sale of a wide range of pharmaceutical products and medical devices. It provides products for human health and well-being. J&J’s product offerings...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME659D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME659D
  • View Report: Research and Experts Company Report: Merck & Co., Inc. (MRK) - Medical Equipment - Deals and Alliances Profile

    Merck & Co., Inc. (MRK) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Merck & Co., Inc. (Merck) is a healthcare company, which focuses on the discovery, development, manufacture and commercialization of branded pharmaceuticals, biologic therapies, prescription and over-the-counter (OTC) medicines, vaccines, consumer...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME6319D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME6319D
  • View Report: Research and Experts Company Report: Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile

    Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Merck KGaA (Merck) is a pharmaceutical and chemical company, which operates its business in three markets namely, pharmaceuticals market, high-tech materials market and life sciences market. Its business operations include promoting prescription drugs...
  • Company Report
  • Medical Devices
  • Germany
  • $250.00
  • Report 05IB-GDME48505D has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GDME48505D
  • View Report: Research and Experts Company Report: Genentech, Inc. - Medical Equipment - Deals and Alliances Profile

    Genentech, Inc. - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Genentech, Inc. (Genentech) is a biotech company that undertakes discovery, development, manufacture and commercialization of medicines for the treatment of patients with serious medical conditions. The company focuses on developing drugs for unmet medica...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME4341D has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDME4341D
  • View Report: Research and Experts Company Report: GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile

    GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    GlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cardiovascular, metabol...
  • Company Report
  • Medical Devices
  • United Kingdom
  • $250.00
  • Report 05IB-GDME4279D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME4279D
  • View Report: Research and Experts Company Report: Shire Plc (SHP) - Medical Equipment - Deals and Alliances Profile

    Shire Plc (SHP) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Shire Plc (Shire) is a specialty biopharmaceutical company, which focuses on the research, development and commercialization of specialty pharmaceutical products for rare diseases and other serious conditions. It provides products for rare diseases, neuro...
  • Company Report
  • Medical Devices
  • Ireland
  • $250.00
  • Report 05IB-GDME40168D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME40168D
  • View Report: Research and Experts Company Report: Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile

    Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Sanofi is a healthcare company, which focuses on the research, development, manufacture and marketing of therapeutic solutions.The company offers a wide range of medicines, vaccines and innovative therapeutic solutions. Its product portfolio includes...
  • Company Report
  • Medical Devices
  • France
  • $250.00
  • Report 05IB-GDME3811D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME3811D
  • View Report: Research and Experts Company Report: Amgen Inc. (AMGN) - Medical Equipment - Deals and Alliances Profile

    Amgen Inc. (AMGN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Amgen Inc. (Amgen) is a biotechnology company. It undertakes the discovery, development, manufacture and commercialization of innovative human therapeutics. The company pioneered the development of new products based on advances in recombinant DNA and...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME3778D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME3778D
  • View Report: Research and Experts Company Report: Pfizer Inc. (PFE) - Medical Equipment - Deals and Alliances Profile

    Pfizer Inc. (PFE) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Pfizer Inc. (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. It offers products for the treatment of respi...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME32190D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME32190D
  • View Report: Research and Experts Company Report: Mylan N.V. (MYL) - Medical Equipment - Deals and Alliances Profile

    Mylan N.V. (MYL) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Mylan N.V., formerly, Mylan Inc. is one of the leading generic drug and specialty drug manufacturing companies in the world. The company focuses on the development, licensing, production, commercialization and distribution of generics, branded generics,...
  • Company Report
  • Medical Devices
  • United Kingdom
  • $250.00
  • Report 05IB-GDME31565D has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDME31565D
  • View Report: Research and Experts Company Report: Dr. Reddy

    Dr. Reddy's Laboratories Limited (DRREDDY) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Dr. Reddy's Laboratories Limited (Dr. Reddy's) is a pharmaceutical company. The company manufactures and markets generic formulations, active pharmaceutical ingredients, biosimilars and proprietary products. The company’s generic products...
  • Company Report
  • Medical Devices
  • India
  • $250.00
  • Report 05IB-GDME28920D has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDME28920D
  • View Report: Research and Experts Company Report: Novartis AG (NOVN) - Medical Equipment - Deals and Alliances Profile

    Novartis AG (NOVN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic products for the treatment of diseases and disorders in humans and animals. It provides drugs for the treatmen...
  • Company Report
  • Medical Devices
  • Switzerland
  • $250.00
  • Report 05IB-GDME24864D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME24864D
  • View Report: Research and Experts Company Report: Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile

    Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Abbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME1255D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME1255D
  • View Report: Research and Experts Company Report: Bristol-Myers Squibb Company (BMY) - Medical Equipment - Deals and Alliances Profile

    Bristol-Myers Squibb Company (BMY) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Bristol-Myers Squibb Company (BMS) is global biopharmaceutical company focused at addressing the unmet medical needs of patients with serious diseases. It undertakes the discovery, development, licensing, manufacture, marketing and distribution of biophar...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME10D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME10D
  • View Report: Research and Experts Company Report: Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review

    Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review


    2016-03-01
    Merck KGaA (Merck) is a pharmaceutical and chemical company, which operates its business in three markets namely, pharmaceuticals market, high-tech materials market and life sciences market. Its business operations include promoting prescription drugs...
  • Company Report
  • Iron and steel Construction
  • Germany
  • $125.00
  • Report 05IB-GDPH48505FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDPH48505FSA
  • View Report: Research and Experts Company Report: Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review

    Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review


    2016-03-01
    Pfizer Inc. (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. It offers products for the treatment of respi...
  • Company Report
  • Iron and steel Construction
  • United States
  • $125.00
  • Report 05IB-GDPH32190FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDPH32190FSA
  • View Report: Research and Experts Company Report: Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review

    Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review


    2016-03-01
    Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic products for the treatment of diseases and disorders in humans and animals. It provides drugs for the treatmen...
  • Company Report
  • Iron and steel Construction
  • Switzerland
  • $125.00
  • Report 05IB-GDPH24864FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDPH24864FSA
  • View Report: Research and Experts Company Report: Shire Plc (SHP) - Financial and Strategic SWOT Analysis Review

    Shire Plc (SHP) - Financial and Strategic SWOT Analysis Review


    2016-02-23
    Shire Plc (Shire) is a specialty biopharmaceutical company, which focuses on the research, development and commercialization of specialty pharmaceutical products for rare diseases and other serious conditions. It provides products for rare diseases, neuro...
  • Company Report
  • Iron and steel Construction
  • Ireland
  • $125.00
  • Report 05IB-GDPH40168FSA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GDPH40168FSA
  • View Report: Research and Experts Market Report: Cancer Cachexia - Pipeline Review, H1 2016

    Cancer Cachexia - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Cancer Cachexia - Pipeline Review, H1 2016’, provides an overview of the Cancer Cachexia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cancer Cachexia,...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7656IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7656IDB
  • View Report: Research and Experts Market Report: Duchenne Muscular Dystrophy - Pipeline Review, H1 2016

    Duchenne Muscular Dystrophy - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2016’, provides an overview of the Duchenne Muscular Dystrophy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7604IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7604IDB
  • View Report: Research and Experts Market Report: Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2016

    Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2016’, provides an overview of the Post-Traumatic Stress Disorder (PTSD) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7580IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7580IDB
  • View Report: Research and Experts Market Report: Alcohol Addiction - Pipeline Review, H1 2016

    Alcohol Addiction - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Alcohol Addiction - Pipeline Review, H1 2016’, provides an overview of the Alcohol Addiction pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Alcohol...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7578IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7578IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H1 2016

    Diabetic Neuropathic Pain - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7576IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7576IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

    The report provides...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7562IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7562IDB
  • View Report: Research and Experts Market Report: Hypoglycemia - Pipeline Review, H1 2016

    Hypoglycemia - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Hypoglycemia - Pipeline Review, H1 2016’, provides an overview of the Hypoglycemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypoglycemia, complete...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7650IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7650IDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2024


    2015-12-17
    Liver cancer is the second leading cause of cancer related death in the world in men and the sixth leading cause of cancer death in women. Hepatocellular carcinoma (HCC) is the most dominant form of liver cancer, accounting for approximately 85% of liver...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC046POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC046POA
  • View Report: Research and Experts Market Report: PharmaPoint: Gastric and Gastroesophageal Junction Adenocarcinoma - Global Drug Forecast and Market Analysis to 2024

    PharmaPoint: Gastric and Gastroesophageal Junction Adenocarcinoma - Global Drug Forecast and Market Analysis to 2024


    2015-12-09
    Gastric and gastroesophageal junction adenocarcinoma (G/GEJAC) represents the majority of gastric cancer cases worldwide. It is the fifth most diagnosed cancer globally, and the third most common cause of cancer death in the world. The major treatments...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC123PIDR has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC123PIDR
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Systemic Sclerosis (Scleroderma) - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Systemic Sclerosis (Scleroderma) - Opportunity Analysis and Forecast to 2024


    2015-12-10
    Systemic sclerosis (SSc) is a complex autoimmune disease that affects the skin and multiple internal organs. Common manifestations of SSc that are included in this report are skin fibrosis, lung fibrosis, and digital vasculopathy (including Raynaud’s...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC044POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC044POA
  • View Report: Research and Experts Market Report: Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2016

    Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2016" provides an overview of Peripheral Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3193CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3193CTIDB
  • View Report: Research and Experts Company Report: Intercept Pharmaceuticals Inc (ICPT) - Financial and Strategic SWOT Analysis Review

    Intercept Pharmaceuticals Inc (ICPT) - Financial and Strategic SWOT Analysis Review


    2016-11-22
    Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops and commercializes treatments for chronic liver and intestinal diseases. It develops products using its proprietary bile acid chemistry. The company’s...
  • Company Report
  • Life Sciences
  • United States
  • $300.00
  • Report 05IC-GDPH138103FSA has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDPH138103FSA
  • View Report: Research and Experts Market Report: Idiopathic (Essential) Hypertension - Pipeline Review, H2 2015

    Idiopathic (Essential) Hypertension - Pipeline Review, H2 2015


    2015-10-30
    Idiopathic (Essential) Hypertension - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H2 2015’, provides an overview of the Idiopathic (Essential) Hypertension’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7256IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7256IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H2 2015

    Osteoarthritis Pain - Pipeline Review, H2 2015


    2015-10-30
    Osteoarthritis Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H2 2015’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7221IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7221IDB
  • View Report: Research and Experts Market Report: Major Depressive Disorder - Pipeline Review, H2 2015

    Major Depressive Disorder - Pipeline Review, H2 2015


    2015-10-30
    Major Depressive Disorder - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Major Depressive Disorder - Pipeline Review, H2 2015’, provides an overview of the Major Depressive Disorder’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7217IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7217IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2015

    Epithelial Ovarian Cancer - Pipeline Review, H2 2015


    2015-10-30
    Epithelial Ovarian Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7214IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7214IDB
  • View Report: Research and Experts Market Report: Renal Anemia - Pipeline Review, H2 2015

    Renal Anemia - Pipeline Review, H2 2015


    2015-10-30
    Renal Anemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Renal Anemia - Pipeline Review, H2 2015’, provides an overview of the Renal Anemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7230IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7230IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015

    Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015


    2015-10-30
    Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2015’, provides an overview of the Adenocarcinoma Of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7228IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7228IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015


    2015-10-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7211IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7211IDB
  • View Report: Research and Experts Market Report: Uveal Melanoma - Pipeline Review, H2 2015

    Uveal Melanoma - Pipeline Review, H2 2015


    2015-10-28
    Uveal Melanoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Uveal Melanoma - Pipeline Review, H2 2015’, provides an overview of the Uveal Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7262IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7262IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Mantle Cell Lymphoma - Pipeline Review, H2 2015


    2015-10-21
    Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6961IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6961IDB
  • View Report: Research and Experts Market Report: Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2015

    Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2015


    2015-10-21
    Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2015’, provides an overview of the Post-Traumatic Stress Disorder (PTSD)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6853IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6853IDB
  • View Report: Research and Experts Market Report: Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2015

    Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2015


    2015-10-21
    Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2015’, provides an overview of the Coronary...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6848IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6848IDB
  • View Report: Research and Experts Market Report: Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015

    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015


    2015-10-21
    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015’, provides an overview of the Metastatic Renal Cell Carcinoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6843IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6843IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H2 2015

    Diabetic Neuropathic Pain - Pipeline Review, H2 2015


    2015-10-14
    Diabetic Neuropathic Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H2 2015’, provides an overview of the Diabetic Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6858IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6858IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015


    2015-10-14
    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015’, provides an overview of the...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6856IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6856IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H2 2015

    Cognitive Impairment - Pipeline Review, H2 2015


    2015-09-30
    Cognitive Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7070IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7070IDB
  • View Report: Research and Experts Market Report: Oligodendroglioma - Pipeline Review, H2 2015

    Oligodendroglioma - Pipeline Review, H2 2015


    2015-09-30
    Oligodendroglioma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H2 2015’, provides an overview of the Oligodendroglioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7173IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7173IDB
  • View Report: Research and Experts Market Report: Cancer Cachexia - Pipeline Review, H2 2015

    Cancer Cachexia - Pipeline Review, H2 2015


    2015-09-30
    Cancer Cachexia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cancer Cachexia - Pipeline Review, H2 2015’, provides an overview of the Cancer Cachexia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6977IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6977IDB
  • View Report: Research and Experts Market Report: Alcohol Addiction - Pipeline Review, H2 2015

    Alcohol Addiction - Pipeline Review, H2 2015


    2015-09-30
    Alcohol Addiction - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Alcohol Addiction - Pipeline Review, H2 2015’, provides an overview of the Alcohol Addiction’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6970IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6970IDB
  • View Report: Research and Experts Market Report: Cachexia - Pipeline Review, H2 2015

    Cachexia - Pipeline Review, H2 2015


    2015-09-30
    Cachexia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cachexia - Pipeline Review, H2 2015’, provides an overview of the Cachexia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6965IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6965IDB
  • View Report: Research and Experts Market Report: Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015

    Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015


    2015-09-23
    Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015’, provides an overview of the Peripheral Artery Occlusive Disease...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7084IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7084IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015


    2015-09-23
    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7083IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7083IDB
  • View Report: Research and Experts Market Report: Pulmonary Arterial Hypertension - Pipeline Review, H2 2015

    Pulmonary Arterial Hypertension - Pipeline Review, H2 2015


    2015-09-23
    Pulmonary Arterial Hypertension - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Pulmonary Arterial Hypertension - Pipeline Review, H2 2015’, provides an overview of the Pulmonary Arterial Hypertension’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7079IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7079IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H2 2015

    Fallopian Tube Cancer - Pipeline Review, H2 2015


    2015-09-23
    Fallopian Tube Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H2 2015’, provides an overview of the Fallopian Tube Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7075IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7075IDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015


    2015-09-16
    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015’, provides an overview of the Transitional Cell...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7098IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7098IDB
  • View Report: Research and Experts Market Report: Anal Cancer - Pipeline Review, H2 2015

    Anal Cancer - Pipeline Review, H2 2015


    2015-09-09
    Anal Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H2 2015’, provides an overview of the Anal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7163IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7163IDB
  • View Report: Research and Experts Market Report: Muscle Atrophy - Pipeline Review, H2 2015

    Muscle Atrophy - Pipeline Review, H2 2015


    2015-09-09
    Muscle Atrophy - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Muscle Atrophy - Pipeline Review, H2 2015’, provides an overview of the Muscle Atrophy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7146IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7146IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H2 2015

    Mild Cognitive Impairment - Pipeline Review, H2 2015


    2015-08-31
    Mild Cognitive Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Mild cognitive impairment - Pipeline Review, H2 2015’, provides an overview of the Mild cognitive impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7058IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7058IDB
  • View Report: Research and Experts Market Report: Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015

    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015


    2015-08-31
    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015’, provides an overview of the Squamous Non-Small Cell Lung Cancer’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6982IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6982IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2015

    Gastric Cancer - Pipeline Review, H2 2015


    2015-08-26
    Gastric Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7055IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7055IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015


    2015-08-19
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7054IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7054IDB
  • View Report: Research and Experts Market Report: Hypoglycemia - Pipeline Review, H2 2015

    Hypoglycemia - Pipeline Review, H2 2015


    2015-08-12
    Hypoglycemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Hypoglycemia - Pipeline Review, H2 2015’, provides an overview of the Hypoglycemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7030IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7030IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2015

    Bladder Cancer - Pipeline Review, H2 2015


    2015-07-31
    Bladder Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H2 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6939IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6939IDB
  • View Report: Research and Experts Market Report: Malignant Glioma - Pipeline Review, H2 2015

    Malignant Glioma - Pipeline Review, H2 2015


    2015-07-31
    Malignant Glioma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Malignant Glioma - Pipeline Review, H2 2015’, provides an overview of the Malignant Glioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6872IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6872IDB
  • View Report: Research and Experts Market Report: Metastatic Prostate Cancer - Pipeline Review, H2 2015

    Metastatic Prostate Cancer - Pipeline Review, H2 2015


    2015-07-31
    Metastatic Prostate Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Prostate Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6865IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6865IDB
  • View Report: Research and Experts Market Report: Chronic Plaque Psoriasis - Pipeline Review, H2 2015

    Chronic Plaque Psoriasis - Pipeline Review, H2 2015


    2015-07-31
    Chronic Plaque Psoriasis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Chronic Plaque Psoriasis - Pipeline Review, H2 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6862IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6862IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2015

    Metastatic Breast Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6507IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6507IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-06-30
    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Glioblastoma Multiforme (GBM)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6676IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6676IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2015

    Ovarian Cancer - Pipeline Review, H1 2015


    2015-06-30
    Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6675IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6675IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2015

    Pancreatic Cancer - Pipeline Review, H1 2015


    2015-06-30
    Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6674IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6674IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2015

    Liver Cancer - Pipeline Review, H1 2015


    2015-06-30
    Liver Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2015’, provides an overview of the Liver Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6563IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6563IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler

    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015


    2015-06-30
    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015’, provides an overview of the Multiple Myeloma (Kahler's Disease)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6505IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6505IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2015

    Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6504IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6504IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2015

    Melanoma - Pipeline Review, H1 2015


    2015-06-30
    Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2015’, provides an overview of the Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6503IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6503IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2015

    Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6502IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6502IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-06-30
    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6498IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6498IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-30
    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6495IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6495IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Metastatic Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6570IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6570IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-30
    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Chronic Lymphocytic Leukemia (CLL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6567IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6567IDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease - Pipeline Review, H1 2015


    2015-06-30
    Parkinson's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2015’, provides an overview of the Parkinson's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6562IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6562IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2015

    Rheumatoid Arthritis - Pipeline Review, H1 2015


    2015-06-30
    Rheumatoid Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6561IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6561IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Hepatocellular Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6499IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6499IDB
  • View Report: Research and Experts Market Report: Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Inflammatory Bowel Disease - Pipeline Review, H1 2015


    2015-06-30
    Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H1 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6494IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6494IDB
  • View Report: Research and Experts Market Report: Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

    Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015


    2015-06-30
    Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015’, provides an overview of the Transitional...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6814IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6814IDB
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H1 2015

    Osteoarthritis - Pipeline Review, H1 2015


    2015-06-30
    Osteoarthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2015’, provides an overview of the Osteoarthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6571IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6571IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease - Pipeline Review, H1 2015


    2015-06-30
    Crohn's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H1 2015’, provides an overview of the Crohn's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6569IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6569IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2015

    Schizophrenia - Pipeline Review, H1 2015


    2015-06-30
    Schizophrenia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2015’, provides an overview of the Schizophrenia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6568IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6568IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H1 2015

    Tuberculosis - Pipeline Review, H1 2015


    2015-06-30
    Tuberculosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2015’, provides an overview of the Tuberculosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6566IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6566IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H1 2015

    Hypertension - Pipeline Review, H1 2015


    2015-06-30
    Hypertension - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2015’, provides an overview of the Hypertension’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6565IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6565IDB
  • View Report: Research and Experts Market Report: Kidney Cancer - Pipeline Review, H1 2015

    Kidney Cancer - Pipeline Review, H1 2015


    2015-06-30
    Kidney Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Kidney Cancer - Pipeline Review, H1 2015’, provides an overview of the Kidney Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6492IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6492IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2015

    Neuropathic Pain - Pipeline Review, H1 2015


    2015-06-30
    Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6491IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6491IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6490IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6490IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer Squamous...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6515IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6515IDB
  • View Report: Research and Experts Market Report: Osteoporosis - Pipeline Review, H1 2015

    Osteoporosis - Pipeline Review, H1 2015


    2015-06-30
    Osteoporosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoporosis - Pipeline Review, H1 2015’, provides an overview of the Osteoporosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6572IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6572IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6518IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6518IDB
  • View Report: Research and Experts Market Report: Hypercholesterolemia - Pipeline Review, H1 2015

    Hypercholesterolemia - Pipeline Review, H1 2015


    2015-06-24
    Hypercholesterolemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hypercholesterolemia - Pipeline Review, H1 2015’, provides an overview of the Hypercholesterolemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6694IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6694IDB
  • View Report: Research and Experts Market Report: Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2015

    Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2015


    2015-06-24
    Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2015’, provides an overview of the Attention Deficit Hyperactivity...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6693IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6693IDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H1 2015

    Migraine - Pipeline Review, H1 2015


    2015-06-24
    Migraine - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2015’, provides an overview of the Migraine’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6692IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6692IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Small-Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-24
    Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6686IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6686IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Myelodysplastic Syndrome - Pipeline Review, H1 2015


    2015-06-24
    Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2015’, provides an overview of the Myelodysplastic Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6685IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6685IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2015

    Bladder Cancer - Pipeline Review, H1 2015


    2015-06-24
    Bladder Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6683IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6683IDB
  • View Report: Research and Experts Market Report: Atherosclerosis - Pipeline Review, H1 2015

    Atherosclerosis - Pipeline Review, H1 2015


    2015-06-24
    Atherosclerosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Atherosclerosis - Pipeline Review, H1 2015’, provides an overview of the Atherosclerosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6682IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6682IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2015

    Renal Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-24
    Renal Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6681IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6681IDB
  • View Report: Research and Experts Market Report: Abdominal Aortic Aneurysms - Pipeline Review, H1 2015

    Abdominal Aortic Aneurysms - Pipeline Review, H1 2015


    2015-06-17
    Abdominal Aortic Aneurysms - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Abdominal Aortic Aneurysms - Pipeline Review, H1 2015’, provides an overview of the Abdominal Aortic Aneurysms’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6800IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6800IDB
  • View Report: Research and Experts Market Report: Low Back Pain - Pipeline Review, H1 2015

    Low Back Pain - Pipeline Review, H1 2015


    2015-06-10
    Low Back Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Low Back Pain - Pipeline Review, H1 2015’, provides an overview of the Low Back Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6717IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6717IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathy - Pipeline Review, H1 2015

    Diabetic Neuropathy - Pipeline Review, H1 2015


    2015-06-10
    Diabetic Neuropathy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6713IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6713IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015


    2015-06-10
    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6705IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6705IDB
  • View Report: Research and Experts Market Report: Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015

    Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015


    2015-06-10
    Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015’, provides an overview of the Bipolar Disorder (Manic Depression)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6704IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6704IDB
  • View Report: Research and Experts Market Report: Malignant Mesothelioma - Pipeline Review, H1 2015

    Malignant Mesothelioma - Pipeline Review, H1 2015


    2015-05-29
    Malignant Mesothelioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6582IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6582IDB
  • View Report: Research and Experts Market Report: Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Soft Tissue Sarcoma - Pipeline Review, H1 2015


    2015-05-29
    Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Soft Tissue Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Soft Tissue Sarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6580IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6580IDB
  • View Report: Research and Experts Market Report: Major Depressive Disorder - Pipeline Review, H1 2015

    Major Depressive Disorder - Pipeline Review, H1 2015


    2015-05-29
    Major Depressive Disorder - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Major Depressive Disorder - Pipeline Review, H1 2015’, provides an overview of the Major Depressive Disorder’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6523IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6523IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H1 2015

    Epithelial Ovarian Cancer - Pipeline Review, H1 2015


    2015-05-29
    Epithelial Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6521IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6521IDB
  • View Report: Research and Experts Market Report: Fragile X Syndrome - Pipeline Review, H1 2015

    Fragile X Syndrome - Pipeline Review, H1 2015


    2015-05-29
    Fragile X Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Fragile X Syndrome - Pipeline Review, H1 2015’, provides an overview of the Fragile X Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6721IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6721IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H1 2015

    Psoriatic Arthritis - Pipeline Review, H1 2015


    2015-05-29
    Psoriatic Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2015’, provides an overview of the Psoriatic Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6589IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6589IDB
  • View Report: Research and Experts Market Report: Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2015

    Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2015


    2015-05-29
    Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2015’, provides an overview of the Chronic Kidney Disease...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6586IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6586IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015


    2015-05-29
    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015’, provides an overview of the Adenocarcinoma Of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6533IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6533IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H1 2015

    Osteoarthritis Pain - Pipeline Review, H1 2015


    2015-05-29
    Osteoarthritis Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2015’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6526IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6526IDB
  • View Report: Research and Experts Market Report: Peripheral Neuropathic Pain - Pipeline Review, H1 2015

    Peripheral Neuropathic Pain - Pipeline Review, H1 2015


    2015-05-20
    Peripheral Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Peripheral Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Peripheral Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6747IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6747IDB
  • View Report: Research and Experts Market Report: Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015

    Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015


    2015-05-13
    Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6506IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6506IDB
  • View Report: Research and Experts Market Report: Anaplastic Astrocytoma - Pipeline Review, H1 2015

    Anaplastic Astrocytoma - Pipeline Review, H1 2015


    2015-05-13
    Anaplastic Astrocytoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Anaplastic Astrocytoma - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Astrocytoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6750IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6750IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H1 2015

    Mild Cognitive Impairment - Pipeline Review, H1 2015


    2015-04-30
    Mild Cognitive Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Mild Cognitive Impairment - Pipeline Review, H1 2015’, provides an overview of the Mild Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6544IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6544IDB
  • View Report: Research and Experts Market Report: Post Menopausal Osteoporosis - Pipeline Review, H1 2015

    Post Menopausal Osteoporosis - Pipeline Review, H1 2015


    2015-04-29
    Post Menopausal Osteoporosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Pipeline Review, H1 2015’, provides an overview of the Post Menopausal Osteoporosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6630IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6630IDB
  • View Report: Research and Experts Market Report: Severe Psoriasis - Pipeline Review, H1 2015

    Severe Psoriasis - Pipeline Review, H1 2015


    2015-04-29
    Severe Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Severe Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Severe Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6610IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6610IDB
  • View Report: Research and Experts Market Report: Moderate Psoriasis - Pipeline Review, H1 2015

    Moderate Psoriasis - Pipeline Review, H1 2015


    2015-04-29
    Moderate Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Moderate Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Moderate Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6598IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6598IDB
  • View Report: Research and Experts Market Report: Ureter Cancer - Pipeline Review, H1 2015

    Ureter Cancer - Pipeline Review, H1 2015


    2015-04-15
    Ureter Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ureter Cancer - Pipeline Review, H1 2015’, provides an overview of the Ureter Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6665IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6665IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2015

    Cognitive Impairment - Pipeline Review, H1 2015


    2015-03-31
    Cognitive Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6243IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6243IDB
  • View Report: Research and Experts Market Report: Addiction - Pipeline Review, H1 2015

    Addiction - Pipeline Review, H1 2015


    2015-03-31
    Addiction - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Addiction - Pipeline Review, H1 2015’, provides an overview of the Addiction’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6241IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6241IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2015

    Gastric Cancer - Pipeline Review, H1 2015


    2015-03-31
    Gastric Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6238IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6238IDB
  • View Report: Research and Experts Market Report: Idiopathic (Essential) Hypertension - Pipeline Review, H1 2015

    Idiopathic (Essential) Hypertension - Pipeline Review, H1 2015


    2015-03-31
    Idiopathic (Essential) Hypertension - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H1 2015’, provides an overview of the Idiopathic (Essential) Hypertension’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6418IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6418IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2015

    Psoriasis - Pipeline Review, H1 2015


    2015-03-26
    Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6361IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6361IDB
  • View Report: Research and Experts Market Report: Oligodendroglioma - Pipeline Review, H1 2015

    Oligodendroglioma - Pipeline Review, H1 2015


    2015-03-19
    Oligodendroglioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H1 2015’, provides an overview of the Oligodendroglioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6462IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6462IDB
  • View Report: Research and Experts Market Report: Uveal Melanoma - Pipeline Review, H1 2015

    Uveal Melanoma - Pipeline Review, H1 2015


    2015-03-19
    Uveal Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Uveal Melanoma - Pipeline Review, H1 2015’, provides an overview of the Uveal Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6424IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6424IDB
  • View Report: Research and Experts Market Report: Pulmonary Arterial Hypertension - Pipeline Review, H1 2015

    Pulmonary Arterial Hypertension - Pipeline Review, H1 2015


    2015-03-19
    Pulmonary Arterial Hypertension - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pulmonary Arterial Hypertension - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Arterial Hypertension’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6252IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6252IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H1 2015

    Fallopian Tube Cancer - Pipeline Review, H1 2015


    2015-03-19
    Fallopian Tube Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H1 2015’, provides an overview of the Fallopian Tube Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6248IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6248IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-03-11
    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6256IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6256IDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015


    2015-02-24
    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the Transitional Cell...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6271IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6271IDB
  • View Report: Research and Experts Market Report: Aortic Aneurysm - Pipeline Review, H1 2015

    Aortic Aneurysm - Pipeline Review, H1 2015


    2015-02-18
    Aortic Aneurysm - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Aortic Aneurysm - Pipeline Review, H1 2015’, provides an overview of the Aortic Aneurysm’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6301IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6301IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-02-18
    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6127IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6127IDB
  • View Report: Research and Experts Market Report: Anal Cancer - Pipeline Review, H1 2015

    Anal Cancer - Pipeline Review, H1 2015


    2015-02-10
    Anal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H1 2015’, provides an overview of the Anal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6338IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6338IDB
  • View Report: Research and Experts Market Report: Muscle Atrophy - Pipeline Review, H1 2015

    Muscle Atrophy - Pipeline Review, H1 2015


    2015-02-10
    Muscle Atrophy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Muscle Atrophy - Pipeline Review, H1 2015’, provides an overview of the Muscle Atrophy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6320IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6320IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2015

    Obesity - Pipeline Review, H1 2015


    2015-02-10
    Obesity - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6235IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6235IDB
  • View Report: Research and Experts Market Report: Anxiety Disorders - Pipeline Review, H1 2015

    Anxiety Disorders - Pipeline Review, H1 2015


    2015-02-10
    Anxiety Disorders - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H1 2015’, provides an overview of the Anxiety Disorders’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6131IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6131IDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H1 2015

    Chronic Pain - Pipeline Review, H1 2015


    2015-02-10
    Chronic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H1 2015’, provides an overview of the Chronic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6129IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6129IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2015

    Type 2 Diabetes - Pipeline Review, H1 2015


    2015-02-10
    Type 2 Diabetes - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6121IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6121IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Mantle Cell Lymphoma - Pipeline Review, H1 2015


    2015-01-30
    Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6139IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6139IDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy - Pipeline Review, H1 2015

    Diabetic Nephropathy - Pipeline Review, H1 2015


    2015-01-30
    Diabetic Nephropathy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Nephropathy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6138IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6138IDB
  • View Report: Research and Experts Market Report: Pulmonary Hypertension - Pipeline Review, H1 2015

    Pulmonary Hypertension - Pipeline Review, H1 2015


    2015-01-30
    Pulmonary Hypertension - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pulmonary Hypertension - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Hypertension’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6136IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6136IDB
  • View Report: Research and Experts Market Report: Duchenne Muscular Dystrophy - Pipeline Review, H1 2015

    Duchenne Muscular Dystrophy - Pipeline Review, H1 2015


    2015-01-30
    Duchenne Muscular Dystrophy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Duchenne Muscular Dystrophy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6134IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6134IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2015


    2015-01-30
    Alzheimer's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6229IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6229IDB
  • View Report: Research and Experts Market Report: Fibromyalgia - Pipeline Review, H1 2015

    Fibromyalgia - Pipeline Review, H1 2015


    2015-01-30
    Fibromyalgia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Fibromyalgia - Pipeline Review, H1 2015’, provides an overview of the Fibromyalgia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6175IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6175IDB